WO2015174772A9 - Skin lifting cosmetic composition containing chitosan having fast dissolving property - Google Patents

Skin lifting cosmetic composition containing chitosan having fast dissolving property Download PDF

Info

Publication number
WO2015174772A9
WO2015174772A9 PCT/KR2015/004872 KR2015004872W WO2015174772A9 WO 2015174772 A9 WO2015174772 A9 WO 2015174772A9 KR 2015004872 W KR2015004872 W KR 2015004872W WO 2015174772 A9 WO2015174772 A9 WO 2015174772A9
Authority
WO
WIPO (PCT)
Prior art keywords
chitosan
skin
range
lifting
test
Prior art date
Application number
PCT/KR2015/004872
Other languages
French (fr)
Korean (ko)
Other versions
WO2015174772A1 (en
Inventor
손미경
박순영
Original Assignee
손미경
박순영
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 손미경, 박순영 filed Critical 손미경
Publication of WO2015174772A1 publication Critical patent/WO2015174772A1/en
Publication of WO2015174772A9 publication Critical patent/WO2015174772A9/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof

Definitions

  • the present invention relates to a cosmetic composition for lifting a skin comprising chitosan having a quick solubility, and in particular, comprises chitosan having a quick solubility in a state of beauty and dissolves by the user immediately before use, thereby burdening or adversely affecting the skin. It does not contain preservatives and surfactants that can give, and relates to a cosmetic composition suitable for skin lifting.
  • the cosmetics market shows a three-dimensional market structure in which the vertical axis of 'health' is added to the two-dimensional structure of 'natural' and 'function'.
  • Each element of natural, function, and health is strengthened through the convergence or simplicity of each other in terms of beauty. This 'healthy beauty' should begin by taking away the bad rather than adding the good. No matter how many good ingredients are present, if various chemicals coexist for their fusion, they will never produce good results for the skin.
  • Such a factory mass production method is easy to monitor each process so that consumers can safely consume, strict quality control is made, there is an advantage in terms of manufacturer tracking or after-care for side effects or accidents caused by cosmetic consumption.
  • a consumer may have a cosmetic product having the same second material but having a different function. New purchases are often necessary.
  • chitosan is a natural animal marine polymer having a unique cation in nature, which is compatible with the human body, has no rejection, no side effects, is non-irritating, and is a safe material for the living body. It has many beneficial effects such as activity, skin protective film formation, and impurity adsorption, but until now it has been mainly recognized and used only as a health food to be ingested, and development as a beneficial cosmetic for skin beauty is insufficient.
  • the present invention has been made to solve the problems of the prior art as described above, and includes chitosan having a quick-release in a state of beauty, which can be burdened or adversely affected by the skin to be dissolved and used by the user immediately before use. It does not contain preservatives, surfactants, etc., to provide a cosmetic composition suitable for skin lifting.
  • the cosmetic composition for skin lifting comprising chitosan having a fast dissolving property is a solvent having a degree of deacetylation (DA) within a range of 80 to 100% and a pH within a range of 3.5 to 7.5. 0.5 to 6.0 wt% of chitosan having a fast solubility dissolved at a dissolution rate within a range of 1 to 15 minutes; And a solvent having a pH within a range of 3.5 to 7.5 as a residual amount, wherein the chitosan is physically separated from the solvent and is not dissolved therein.
  • DA degree of deacetylation
  • the chitosan may preferably have a degree of deacetylation within the range of 90 to 100%, more preferably within the range of 95 to 100%.
  • the chitosan may be fibrous chitosan having an average thickness within the range of 0.010 to 0.050 mm, fibrous chitosan may be included in an amount within the range of 1.7 to 4.0% by weight.
  • the chitosan may be powdery chitosan having an average thickness within the range of 0.150 to 0.450 mm, powdery chitosan may be included in an amount within the range of 2.6 to 6.0% by weight.
  • the solvent is water; Or glycolic acid, lactic acid, lactic acid, citric acid, malic acid, tartaric acid, citric acid, ascorbic acid (vitamin C), ascorbyl phosphate, ascorbyl glucoside, magnesium ascorbyl phosphate, sodium ascorbyl phosphate, ascorbic Acid may be dissolved in a pH adjuster selected from the group consisting of bilpalmitate and a mixture of two or more thereof.
  • the present invention contains chitosan having a fast solubility in a state of beauty, and does not include preservatives and surfactants that can burden or adversely affect the skin by dissolving it by the user immediately before use, and lifting the skin.
  • a suitable cosmetic composition for the use it is possible to prevent the danger of chemical preservatives, especially skin troubles, which are pointed out as problems in the prior art, and to use cosmetics immediately when using natural materials that are safe for the skin by using the properties of the raw materials. It is prepared to provide the effect of allowing the skin to apply the efficacy effect of the raw material to the freshest.
  • FIG. 1 to 6 are photographs of the fibrous chitosan used in the solubility test according to the thickness of chitosan, in particular fibrous chitosan and powdery chitosan, used in the present invention.
  • FIG. 9 is a photograph showing a state in which the fungus bacteria cultivated after 10 days by storing the chitosan solution at room temperature.
  • 10 to 16 are graphs showing measurement data values of the eye tail lifting angle before use and after 2 weeks of use, in order to confirm the lifting value change of each wrinkle area.
  • the cosmetic composition for skin lifting comprising chitosan having rapid solubility has a degree of deacetylation (DA) within the range of 80 to 100% and within the range of 3.5 to 7.5.
  • DA degree of deacetylation
  • the cosmetic composition for skin lifting comprising chitosan having a fast dissolving property is a solvent having a degree of deacetylation (DA) within a range of 80 to 100% and a pH within a range of 3.5 to 7.5. 0.5 to 6.0 wt% of chitosan having a fast solubility dissolved at a dissolution rate within a range of 1 to 15 minutes; And a solvent having a pH within a range of 3.5 to 7.5 as a residual amount, wherein the chitosan is physically separated from the solvent and is not dissolved therein.
  • DA degree of deacetylation
  • chitosan is defined as meaning chitosan having water and / or pH within an acidic range and dissolved in acidic water obtained by including an acidic substance in water based on water.
  • the chitosan may preferably have a degree of deacetylation within the range of 90 to 100%, more preferably within the range of 95 to 100%.
  • Chitosan which is a raw material of chitosan, is a deacetylated product obtained by deacetylating chitin obtained from shells of crustaceans, and is soluble in water, in particular weak acids, and is easily absorbed by the human body. It is one of and functions as one ingredient that gives skin lifting effect when applied to the skin.
  • Chitosan is a glucosamine polymer obtained by alkali treatment of chitin, which is found in shellfish such as shrimp, crabs, insect shells, and squid bones.
  • the main component is polyglucosamine, a colorless amorphous powder with a polymer structure.
  • Chitosan which is a glucosamine bond, has a molecular structure very similar to that of our human tissues, and is very valuable as a food and drug because it has a very good human affinity and no immune response occurs.
  • the degree of deacetylation of chitosan can be measured using colloid titration as described in K. Toei and T. Kohara, Analytica Chimica Acta, 83, 59-65 (1976).
  • the chitosan may have a degree of deacetylation within the range of 80 to 100%, preferably within the range of 90 to 100%, more preferably within the range of 95 to 100%.
  • the deacetylation degree is less than 80%, not only the solubility of chitosan decreases but also the amount of undissolved solids increases, which is not suitable for application or application to the skin, such as heavy metals (lead, chromium, cadmium, etc.). There may be a problem that harmful substances and other impurities remain to adversely affect the skin.
  • the fibrous chitosan may have an average thickness within the range of 0.010 to 0.050 mm, preferably within the range of 0.015 to 0.040 mm.
  • the average thickness of the fibrous chitosan is less than 0.010 mm, the dissolution rate may be increased, but there may be a problem in that the handling and manufacturing of the fibrous form is complicated or difficult, and on the contrary, when the average thickness of the fibrous chitosan exceeds 0.050 mm, the dissolution rate There is a problem that the property of the fast solubility disappears late, and it becomes inconvenient to dissolve and use by the user immediately before use.
  • Fibrous chitosan may be included in amounts within the range of 1.7 to 4.0 weight percent.
  • the chitosan may be powdery chitosan having an average thickness within the range of 0.150 to 0.450 mm, preferably within the range of 0.190 to 0.400 mm, more preferably within the range of 0.195 to 0.395 mm, powdery chitosan is 2.6 to 6.0 It may be included in an amount within the range of weight percent.
  • the fibrous chitosan can be obtained by dissolving chitosan in acid, stirring and processing by wet spinning. At this time, after the processing, washing and drying process, the used acid is removed and does not remain, so that the solubility of chitosan by the use of the acid in the form of salt increases.
  • the powdery chitosan can be obtained by grinding the chitosan, which also increases the solubility in the form of a salt.
  • the chitosan may have a dissolution rate dissolved in a solvent having a pH within the range of 3.5 to 7.5 within 1 to 15 minutes, preferably within the range of 5 to 10 minutes. If the dissolution rate is less than 1 minute, there is no particular problem, but in order to increase the dissolution rate requires a lot of effort and time in the production of chitosan, there may be a problem that the productivity is lowered, on the contrary exceeding 15 minutes immediately before use There may be a problem that it is inconvenient to dissolve and use by the user.
  • the above dissolution rate is generally adjusted to 10 to 15 minutes, which is a time range during which women wash face, and is intended to be mixed, dissolved, and used after cleansing before washing.
  • the chitosan may be included in an amount within the range of 0.5 to 6.0% by weight, preferably 0.9 to 1.4% by weight based on the total weight of the cosmetic composition according to the present invention.
  • the content of the chitosan is less than 0.5% by weight, the chitosan solution obtained by dissolving the chitosan in the solvent is too low, the skin lifting effect is lowered, there may be a problem such as lowering the customer satisfaction On the contrary, if it exceeds 6.0% by weight, the viscosity of the obtained chitosan solution is too high, it is difficult or inconvenient to apply to the skin may also have a problem such as lowering the customer satisfaction.
  • the solvent is present in the cosmetic composition according to the present invention in a state separated from the chitosan and functions to facilitate the application of chitosan to the skin by dissolving the chitosan by the user immediately before use.
  • Chitosan hardly decomposes or denatures at room temperature in the dried solid state, but once dissolved and in solution, it easily decomposes at room temperature, and molds grow well.
  • the present invention is characterized in that the chitosan is kept in a dry solid state, thereby avoiding the use of a preservative.
  • the chitosan is kept in a dry solid state and dissolved in a solvent immediately before use, so that the chitosan solution having a high viscosity with almost no decomposition can be applied immediately to the skin.
  • a cosmetic composition with excellent effect can be provided.
  • the solvent may have a pH within the range of 3.5 to 7.5, preferably within the range of 5 to 7.
  • the pH of the solvent is less than 3.5, there is a problem that the acidity is too strong may cause irritation or damage to the skin, which is not suitable for cosmetic use, if it exceeds 7.5, chitosan is not dissolved or dissolution rate There may be a problem that is too slow to be dissolved by the user immediately before use is inconvenient to use.
  • the solvent is water; Or glycolic acid, lactic acid, lactic acid, citric acid, malic acid, tartaric acid, citric acid, ascorbic acid (vitamin C), ascorbyl phosphate, ascorbyl glucoside, magnesium ascorbyl phosphate, sodium ascorbyl phosphate, ascorbic Acid may be dissolved in a pH adjuster selected from the group consisting of bilpalmitate and a mixture of two or more thereof.
  • the water may be fresh water, rock water, deep sea water, mineral water, loess longevity, bamboo salt purified water, ginseng water, red ginseng water, ginseng fruit water, mineral water, carbonated water, germanium water, berry-containing water, mineral-containing water, and two or more of them. It may be selected from the group consisting of a mixture.
  • the cosmetics may be further added to various natural raw materials such as functional raw materials, such as arbutin, adenosine, green tea or green tea extract, depending on the characteristics of the product.
  • functional raw materials such as arbutin, adenosine, green tea or green tea extract
  • the cosmetic composition for skin lifting comprising a quick-release chitosan according to the present invention having the configuration features as described above comprises a solvent suitable for rapidly dissolving the chitosan with a quick-to-use property, and immediately before use. It allows the user to immediately use the chitosan after dissolving it in the solvent, and according to such configuration features, unlike conventional chitosan-containing cosmetics, it is stored after preparation without using synthetic additives such as preservatives and surfactants.
  • Powdered chitosan or fibrous chitosan prepared using chitosan only
  • the dissolution time was measured using the time until no change was seen as the dissolution time.
  • the solvent used was acidic water of pH 4 obtained by dissolving glycolic acid in water (1.2 wt% fibrous chitosan, 98.8 wt% acidic water), and the instrument used for measuring the thickness of fibrous chitosan was manufactured by e Scope Professional PRO (manufactured by Company name: OiTEZ Co., Ltd. in China, and the magnification was 500 times.
  • Fibrous chitosan of FIG. 1 had an average thickness of 0.0153 mm, and a dissolution time was about 7 minutes.
  • Fibrous chitosan in FIG. 2 had an average thickness of 0.0215 mm, and the dissolution time was about 9 minutes.
  • Fibrous chitosan in FIG. 3 had an average thickness of 0.03979 mm, and the dissolution time was about 13 minutes.
  • Fibrous chitosan of FIG. 4 had an average thickness of 0.2697 mm and was found to be impossible to dissolve completely within 1 hour.
  • the powdery chitosan of FIG. 5 was found to have an average particle diameter of 0.332386 mm, 0.195323 mm and 0.350297 mm, respectively.
  • the powdery chitosan of FIG. 6 was found to have an average particle diameter of 0.296869 mm, 0.390526 mm and 0.222697 mm, respectively.
  • Solubility was measured using fibrous yarns (manufactured using chitosan only) having the same thickness (0.025 mm) except that each had a different degree of deacetylation.
  • the solvent used was acidic water of pH 4 obtained by dissolving glycolic acid in water (1.2% by weight of fibrous chitosan, 98.8% by weight of acidic water), and the results of the solubility experiment are shown in the photograph of FIG. 7.
  • solubility increased with increasing deacetylation degree.
  • deacetylation degree of 70% and 75% it was confirmed that the solubility was so low that the cosmetically solid content that was difficult to apply to the skin was largely visible to the naked eye, whereas in 80% to 90%, the solid content was visually It showed solubility that can be used for the purpose of this show or cosmetics, and it was confirmed that at 90% or more, the undissolved solids exhibited high solubility that cannot be seen with the naked eye.
  • Experimental Example 3 Test for measuring the physical properties of the obtained chitosan solution and dissolution time according to the content of fibrous chitosan and powdery chitosan prepared from chitosan
  • powdery chitosan and fibrous chitosan were prepared using chitosan having a deacetylation degree of 95%, and the physical properties of the chitosan solution obtained after solubility and dissolution were measured. 1-1 to Table 1-6). At this time, the powdery chitosan was an average particle diameter of 0.298mm, the fibrous chitosan was an average thickness of 0.025mm, and the acidic water of pH 4 adjusted to pH with purified water or glycolic acid was used as a solvent. The measurement of the viscosity was performed at room temperature (25 ° C).
  • chitosan insoluble means that it is insoluble in neutral water and dissolved in acidic water (glycolic acid is used as AHA acid), and the powder is powdered, and the yarn is made in fibrous form.
  • chitosan water solubility means that it is soluble in neutral water, and the powder is powder, meaning that the yarn is made of fibrous.
  • both the powdery chitosan and the fibrous chitosan showed a tendency to increase the viscosity consistently with the increase in the amount, in particular according to the present invention.
  • Fibrous chitosan showed a higher viscosity, and as the dosage increased, fibrous chitosan showed a much greater increase in viscosity compared to powdery chitosan.
  • chitosan solutions by concentration of 0.5% to 2.0% by weight (the remaining amount is acidic water used in the above experiments), and adult women from 20s to 50s by age group (ie, 20s and 30s).
  • 40's and 50's consisted of a total of 120 panels of 30 people, and each panel was provided with chitosan solutions for each concentration (total 16 species), and then randomly used for 1 month, and then 1 month.
  • the preference sensory test was performed to check the chitosan solution of the most preferred concentration at the elapsed time point, and the results are shown in Table 2 below.
  • the chitosan solutions for each concentration were prepared by increasing the concentration of 0.5 to 0.1 wt% in the range of 0.5 wt% to 2.0 wt%, and the prepared chitosan solutions were prepared at low concentration and high concentration.
  • English alphabets (A to P) were sequentially assigned to the panel and provided to the panel.
  • the chitosan concentration within the range of 0.9% to 1.3% was high overall preference, in particular within the range of 1.0% to 1.2% was relatively higher, 1.1% and 1.2% relative The concentration was very high, and among them, the concentration of 1.2% was the most preferred. Especially, the concentration of 1.1% by weight was evenly high in the 20s and 40s, but the relative 1.2% by weight was especially high in the 40s and 50s. .
  • a fibrous chitosan having an average thickness of 0.025 mm was prepared using chitosan having a deacetylation degree of 95%, and glycolic acid was dissolved in purified water to prepare acidic water having a pH of 4, and the acidic water
  • a cosmetic composition was prepared by dissolving 1.2% by weight of the fibrous chitosan in 98.8% by weight, which was used for a lifting effect experiment.
  • Test product cosmetic composition of the above description
  • Subjects Women aged 20 to 55 who meet the subject selection and exclusion criteria
  • Exclusion Criteria for Subject Selection Any one of the following exclusion criteria cannot participate in this test.
  • Test Method Subjects who agreed to participate in the human body application test and met the selection criteria and exclusion criteria were to use the test product for 2 weeks. Subjects used the test product at visit 1 and evaluated the test site before and immediately after using the product. The same test site was evaluated two weeks after use of the product at visit 2, and the validity and preference questionnaire evaluation was completed after the end of the test.
  • Visit 1 Subject acceptance, subject selection inspection, measurement before and after use of product, product distribution
  • Evaluation site and measuring method For mechanical evaluation, the test subject is allowed to settle for 30 minutes in an air-conditioned room with a room temperature of 20 to 25 and a humidity of 40 to 60% to adjust the skin surface temperature and humidity to the environment of the measurement space. During rest, water intake was limited. One investigator was measured for objective measurement, and the same area was measured at each measurement.
  • Skin lifting measurement was performed by analyzing the image of the eyes, cheeks and mouth area using Image-pro plus for images taken using F-ray, a device that expresses the appearance of the skin in contours.
  • the tail lifting was evaluated by drawing a straight line based on the tip of the tail and measuring the angle with the line across the tip of the tail. As the angle between the two straight lines increases, it can be seen that there is an eye tail lifting effect.
  • Facial lifting was evaluated by drawing a straight line in the center of the circle based on the circle formed near the cheekbone and measuring the angle with the straight line across the mouth. It can be seen that the smaller the angle between the two straight lines has the ball lifting effect.
  • Mouth lifting was evaluated by drawing a straight line based on the tip of the mouth and measuring the angle with the line drawn from the center of the circle based on the circle formed near the tip of the mouth and the cheekbones. As the angle between the two straight lines increases, it can be seen that there is a particle lifting effect.
  • Skin-palm wrinkle measurement The skin-palm wrinkle measurement was taken on the same area in the palm area before and immediately after using the test product using the 3D skin imaging device (Primos Pico), and after 2 weeks, Ra (mean roughness parameter) of the skin wrinkle parameter of the stored image. : average roughness) value was analyzed.
  • Skin Neck Wrinkle Measurement Skin neck wrinkle measurement was performed using 3D skin imaging device (Primos Pico) before and immediately after use of the test product, two weeks after the same part of the neck was taken, and the skin wrinkle parameter Ra (average roughness) of the stored image. : average roughness) value was analyzed.
  • Skin moisture content measurement was measured using Corneometer CM825 (Courage-Khazaka electronic GmbH, Germany) before and immediately after use of the test product and two weeks after use. The measurement was performed three times through the sensor by contacting the corneometer probe with the skin, and the average value was used as an evaluation data for skin moisture content.
  • the corneometer can measure the moisture content by measuring the capacitance at the point of contact of the probe. The unit is A.U, which is a unit constant, and the skin moisturization and the measured value are proportional.
  • Skin keratin measurement The skin keratin measurement was measured before and immediately after using the test product and two weeks after using Visioscan VC98 (Courage-Khazaka eletronic GmbH, Germany). The measurement was performed by using a special film (Corneofix), and after taking the keratin of the cheek area, images were taken and analyzed by Visioscan VC98, and the measured value DI (Desquamation Index) was used as the evaluation data of the skin keratin. Calculated using.
  • D.I is the epidermal loss index (%)
  • A is the percentage of area covered with keratinocytes
  • Tn is the percentage of keratinocytes associated with thickness
  • n is the level of thickness (1-5).
  • Safety evaluation The safety of the test product was calculated by integrating the identified adverse reactions among all subjects using the test product and all reported adverse reactions during the test period, and used as the safety evaluation data of the product.
  • Product preference survey evaluation The test subjects were asked to answer the questionnaire directly about the product feeling after using the test product. The evaluation items were examined on skin moistness, smoothness, softness, spreadability, scent, and overall feeling of use, and were evaluated as good (4), good (3), moderate (2), bad (1), and bad (0). It was evaluated in five stages.
  • Adverse reaction evaluation Abnormal skin symptoms occurred during the use of the test product were examined during the test period to determine the occurrence and symptoms. If the subject felt abnormal, he / she was instructed to report it immediately. The investigator informed the responsible investigator when an adverse reaction was reported, and the lead investigator judged the extent of the symptom, the association with the test product, and determined the appropriate measures for the symptom and participation in the test.
  • the primary efficacy parameters of the test product are measured before and after use of the test product, including skin moisture content, wrinkles (forehead, eyes, and limbs), pores, blemishes, lifting, fastness, resilience, and brown spot measurements. It evaluated on the basis.
  • Secondary efficacy evaluation variables Secondary efficacy evaluation variables of the test product were evaluated based on the results of the efficacy survey for skin improvement effects after using the test product.
  • the tail tail lifting angle before and after two weeks of use was measured.
  • the tail lifting angle measurement was 46.08 ⁇ 10.42 before use, 46.78 ⁇ 10.56 immediately after use, and 48.10 ⁇ 10.33 after 2 weeks of use. Changes in skin lifting angle were tested for statistical significance.
  • post hoc Bonferroni correction which is a parametric method according to the normality test, it was confirmed that the tail lifting angle increased significantly (p ⁇ 0.05) immediately after use and after 2 weeks compared to before use. there was.
  • the ball lifting angle was measured before use and 2 weeks after use in order to confirm the change of the ball lifting value by using the test product.
  • the ball lifting angle measurement was 36.34 ⁇ 7.40 before using the test product, 35.74 ⁇ 7.33 immediately after using, and 34.95 ⁇ 7.34 after 2 weeks of using. Changes in skin lifting angle were tested for statistical significance. According to the normalized test, the repeated measures ANOVA (post hoc Bonferroni correction), a parametric method, showed that the ball lifting angle was significantly decreased (p ⁇ 0.05) immediately after and 2 weeks after use. .
  • the nasolabial folds were measured before use and two weeks after use.
  • the nasolabial fold measurements were 19.87 ⁇ 2.96 before using the test product, 18.76 ⁇ 2.64 immediately after using the test product, and 18.32 ⁇ 2.86 after 2 weeks of using the test product.
  • the change of skin palsy was statistically tested for statistical significance.
  • the non-parametric Friedman test post hoc Wilcoxon signed rank test with Bonferroni correction
  • the neck wrinkles were measured before use and two weeks after use in order to confirm the change of the neck wrinkles caused by the use of the test product.
  • the measured neck wrinkles were 23.88 ⁇ 2.75 before use, 22.44 ⁇ 3.19 immediately after use, and 21.79 ⁇ 2.88 after 2 weeks of use.
  • the change in skin wrinkles was tested by statistical method. According to the normalized test, repeated measures ANOVA (post hoc Bonferroni correction), a parametric method, showed that the neck angle decreased significantly (p ⁇ 0.05) immediately after and 2 weeks after use. .
  • Results of Survey on Product Acceptance Survey A survey was conducted after the use of the product to examine the degree of acceptance of the test subjects regarding the skin's moisture, smoothness, softness, spreadability, aroma, and overall feeling of use. The survey results were expressed as the average standard deviation of the answers for each item, the results are shown in Table 4 below.
  • test subjects evaluated the skin moisture, smoothness, softness, spreadability, fragrance, and overall feeling of use of the test product as above average.
  • Test Results In this study, the test product was used for women aged 20 to 55 years once and for 2 weeks before and immediately after using the product, and after 2 weeks. Lifting, nasolabial folds, neck wrinkles, moisture content, and keratin were measured. After the completion of the test, the subjects' survey was completed, and the following conclusions were obtained.
  • neck wrinkles measured value decreased significantly (p ⁇ 0.05) immediately after use and after 2 weeks.
  • the cosmetic composition according to the present invention provides immediate eye tail lifting improvement, mouth lifting improvement, facial sag (ball lifting) improvement, nasolabial fold improvement, neck wrinkle improvement, moisture content improvement, keratin improvement by two-time use, and use for two weeks. It is believed to be a product that helps to improve eye tail lifting, mouth lifting, facial sagging (ball lifting), nasolabial folds, neck wrinkles, moisture, and keratin.
  • the present invention can be used in the field of industry.

Abstract

The present invention relates to a cosmetic composition which: does not contain a preservative, a surfactant and the like capable of burdening or having an adverse effect on the skin since the cosmetic composition contains chitosan having a fast dissolving property in an undissolved state and is used by allowing chitosan to be dissolved by a user just before use; and is suitable for skin lifting, the cosmetic composition comprising: 0.5-6.0 wt% of chitosan, having a fast dissolving property, dissolved with a dissolution velocity, in the range of 1-15 minutes, in a solvent having a degree of deacetylation (DA) in the range of 80-100% and a pH in the range of 3.5-7.5; and the remainder being a solvent having a pH in the range of 3.5-7.5, wherein the chitosan is physically separated from the solvent and contained in an undissolved state.

Description

속용성을 갖는 키토산을 포함하는 피부 리프팅용 화장조성물Cosmetic composition for skin lifting containing chitosan having fast solubility
본 발명은 속용성을 갖는 키토산을 포함하는 피부 리프팅용 화장조성물에 관한 것으로 특히, 속용성을 갖는 키토산을 미용해 상태로 포함하며, 사용 직전에 사용자에 의해 용해시켜 사용토록 함으로써 피부에 부담 내지는 악영향을 줄 수 있는 방부제와 계면활성제 등을 포함하지 않으며, 피부 리프팅용으로 적절한 화장조성물에 관한 것이다.The present invention relates to a cosmetic composition for lifting a skin comprising chitosan having a quick solubility, and in particular, comprises chitosan having a quick solubility in a state of beauty and dissolves by the user immediately before use, thereby burdening or adversely affecting the skin. It does not contain preservatives and surfactants that can give, and relates to a cosmetic composition suitable for skin lifting.
환경오염 문제가 심각해지고 원인 모를 피부 트러블로 인해 천연 원료의 화장품을 찾는 사람들이 늘고 있다. 또한 웰빙에 대한 관심이 높아지며 천연 원료는 원료적 특성에 힘입어 웰빙생활법의 시작으로 자연스럽게 자리를 잡아가고 있다. 내추럴은 영원한 화장품의 중심 컨셉이며, 이를 어떻게 개선, 진보시키느냐가 과제이다. The problem of environmental pollution is getting serious and the cause of skin trouble is increasing, and more and more people are looking for cosmetics made from natural ingredients. In addition, as interest in well-being increases, natural raw materials are naturally taking place as the beginning of the well-being lifestyle method based on raw material characteristics. Natural is the central concept of eternal cosmetics, and how to improve and advance it is a challenge.
화장품 시장은 '내추럴' 과 '기능'의 2차원적 구조에 '건강'이라는 수직축이 더해진 3차원적 시장 구도를 보이고 있다. 내추럴, 기능, 건강의 각 요소가 서로 미(美)라는 관점에서 상호 간에 융합되거나 단순함을 통해 더욱 강화되고 있다. 이러한 '건강한 아름다움'은 좋은 것을 더하는 것보다 나쁜 것을 빼 나가는 것에서부터 시작되어야 한다. 아무리 좋은 성분이 많이 들어있어도 이들의 융합을 위해 여러 가지 화학성분이 공존한다면 결코 피부에 좋은 결과를 가져오지 못할 것이다.The cosmetics market shows a three-dimensional market structure in which the vertical axis of 'health' is added to the two-dimensional structure of 'natural' and 'function'. Each element of natural, function, and health is strengthened through the convergence or simplicity of each other in terms of beauty. This 'healthy beauty' should begin by taking away the bad rather than adding the good. No matter how many good ingredients are present, if various chemicals coexist for their fusion, they will never produce good results for the skin.
화장품은 의약품이 아닌 이상, 즉효(즉시적인 효과)보다는 피부에 좀 더 안전한 원료물질, 좀 더 신선한 제품, 좀 더 기능적인 제품을 사용하는 것이 중요하며, 이러한 소비자의 욕구는 이미 세계적인 흐름이 되고 있다. 1년 내지 2년의 유통기한, 용량에 따른 재사용의 문제로 필수적으로 함유되어 있는 화학 방부제의 위험성은 화장품 사용자가 겪어야 할 필연적인 문제점이며, 많은 소비자가 피부 트러블을 겪고 있는 것이 현실이다. 이러한 화학 방부제의 위험에서 벗어나기 위해 스스로 천연화장품을 직접 만들어 사용하는 소비자가 매년 눈에 띄게 증가하고 있다. Unless cosmetics are a pharmaceutical, it is important to use safer ingredients, fresher products, and more functional products, which are safer for the skin than immediate effects, and these consumer desires are already becoming a global trend. . The shelf life of one to two years, the risk of chemical preservatives, which are essentially contained as a problem of reuse according to the dose, is an inevitable problem for cosmetic users, and many consumers suffer skin problems. In order to escape the danger of such chemical preservatives, the number of consumers making their own natural cosmetics by themselves is increasing every year.
이에 따라 피부에 가장 안전한 물질과 그 원료물질의 성질을 이용하여 사용 시 즉석에서 화장품을 제조하여 가장 신선하게 원료물질의 효능 효과를 피부에 적용시키는 즉석 화장품 개발 필요성이 요구되어지고 있다.Accordingly, there is a need for the development of instant cosmetics that produce cosmetics on the fly using the safest materials for skin and the properties of the raw materials, and apply the efficacy effect of the raw materials to the skin freshly.
현재 시중에 유통되고 있는 화장품은 공장에서 일괄적으로 이루어지는 대량생산법에 의하여 각각 다른 기능 및 성능을 갖는 하나의 완제품으로 출시되고 있다. 이는 국내 화장품 법상 일정한 제조시설 및 품질관리 시설을 갖추고 당국의 허가를 받은 제조자만이 화장품을 제조할 수 있기 때문이다.Currently, cosmetics in the market are released as a finished product having different functions and performances by mass production method which is collectively performed in a factory. This is because only a manufacturer who has a certain manufacturing facility and quality control facility under the domestic cosmetics law and is authorized by the authorities can manufacture cosmetics.
이러한 공장 대량생산법은 소비자가 안심하고 소비할 수 있도록 각 공정을 모니터하기 용이하고, 엄격한 품질관리가 이루어지며, 화장품 소비에 따른 부작용이나 사고에 대한 제조자 추적이나 사후 관리 측면에서도 유리한 장점이 있다.Such a factory mass production method is easy to monitor each process so that consumers can safely consume, strict quality control is made, there is an advantage in terms of manufacturer tracking or after-care for side effects or accidents caused by cosmetic consumption.
그러나 이러한 공장 대량생산법은 표준화, 규격화, 대량 생산화라는 특성 때문에 소비자의 다양한 욕구를 충족시키지 못할 뿐만 아니라 소비자의 다양한 요구에 능동적으로 대응할 수 없기 때문에 개인 맞춤형 화장품 시장을 활성화시키는 데는 어려움이 있다.However, these factory mass production methods have difficulty in activating the personalized cosmetics market because they cannot satisfy various needs of consumers because of the characteristics of standardization, standardization, and mass production, and also cannot actively respond to various needs of consumers.
또한, 소비자의 필요나 소비목적, 취향과는 상관없이 기업의 필요에 의해 일방적으로 생산된 화장품이 공급되는 경우도 발생하고 있다.In addition, cosmetics produced unilaterally according to the needs of companies are supplied regardless of consumer needs, consumption purposes, or tastes.
일예로, 하나의 화장품에 포함된 제2 재료는 동일하지만 단순한 효능이나 기능성 재료를 부가한 후, 다른 상품으로 시장에 진열되기 때문에 소비자는 동일한 제2재료를 갖는 화장품이 있으면서도 다른 기능을 갖는 화장품을 새로 구입해야 되는 경우가 빈번하다.For example, since a second material included in one cosmetic product is the same but adds a simple efficacy or functional material and then is displayed on the market as another product, a consumer may have a cosmetic product having the same second material but having a different function. New purchases are often necessary.
이에 따라 가정에서 직접 천연의 재료를 이용하여 화장품을 제조하는 소비자가 늘고 있는 실정이다.Accordingly, more and more consumers manufacture cosmetics using natural ingredients at home.
한편, 키토산은 자연계 유일한 양이온을 가지는 천연 동물성 해양 고분자로서 인체와 친화성이 있고, 거부반응, 부작용이 없고, 무자극이며, 생체에 안전한 물질로서, 피부에 작용하여 각질제거, 항균, 보습, 세포활성, 피부보호막 형성, 불순물 흡착 등 많은 유익한 효능을 가지고 있으나, 현재까지는 주로 단순히 섭취하는 건강식품으로만 인식되고 사용되었으며, 피부미용에 유익한 화장품으로서의 개발은 미흡한 상태이다.On the other hand, chitosan is a natural animal marine polymer having a unique cation in nature, which is compatible with the human body, has no rejection, no side effects, is non-irritating, and is a safe material for the living body. It has many beneficial effects such as activity, skin protective film formation, and impurity adsorption, but until now it has been mainly recognized and used only as a health food to be ingested, and development as a beneficial cosmetic for skin beauty is insufficient.
본 발명은 위와 같은 종래 기술의 문제점을 해결하기 위하여 창안한 것으로, 속용성을 갖는 키토산을 미용해 상태로 포함하며, 사용 직전에 사용자에 의해 용해시켜 사용토록 함으로써 피부에 부담 내지는 악영향을 줄 수 있는 방부제와 계면활성제 등을 포함하지 않으며, 피부 리프팅용으로 적절한 화장조성물을 제공하는 것이다.The present invention has been made to solve the problems of the prior art as described above, and includes chitosan having a quick-release in a state of beauty, which can be burdened or adversely affected by the skin to be dissolved and used by the user immediately before use. It does not contain preservatives, surfactants, etc., to provide a cosmetic composition suitable for skin lifting.
본 발명에 따른 속용성을 갖는 키토산을 포함하는 피부 리프팅용 화장조성물은, 80 내지 100%의 범위 이내의 탈아세틸화도(DA: Degree of Deacetylation) 및 3.5 내지 7.5의 범위 이내의 pH를 갖는 용매에서 1 내지 15분의 범위 이내의 용해속도로 용해되는 속용성을 갖는 키토산 0.5 내지 6.0중량%; 및 잔량으로서 3.5 내지 7.5의 범위 이내의 pH를 갖는 용매;를 포함하되, 상기 키토산이 상기 용매로부터 물리적으로 분리되어 용해되어 있지 않은 상태로 포함됨을 특징으로 한다.The cosmetic composition for skin lifting comprising chitosan having a fast dissolving property according to the present invention is a solvent having a degree of deacetylation (DA) within a range of 80 to 100% and a pH within a range of 3.5 to 7.5. 0.5 to 6.0 wt% of chitosan having a fast solubility dissolved at a dissolution rate within a range of 1 to 15 minutes; And a solvent having a pH within a range of 3.5 to 7.5 as a residual amount, wherein the chitosan is physically separated from the solvent and is not dissolved therein.
상기 키토산은 바람직하게는 90 내지 100%의 범위 이내, 보다 바람직하게는 95 내지 100%의 범위 이내의 탈아세틸화도를 갖는 것일 수 있다.The chitosan may preferably have a degree of deacetylation within the range of 90 to 100%, more preferably within the range of 95 to 100%.
상기 키토산은 0.010 내지 0.050㎜의 범위 이내의 평균굵기를 갖는 섬유상 키토산일 수 있으며, 섬유상 키토산은 1.7 내지 4.0중량%의 범위 이내의 양으로 포함될 수 있다.The chitosan may be fibrous chitosan having an average thickness within the range of 0.010 to 0.050 mm, fibrous chitosan may be included in an amount within the range of 1.7 to 4.0% by weight.
상기 키토산은 0.150 내지 0.450㎜의 범위 이내의 평균굵기를 갖는 분말상 키토산일 수 있으며, 분말상 키토산은 2.6 내지 6.0중량%의 범위 이내의 양으로 포함될 수 있다.The chitosan may be powdery chitosan having an average thickness within the range of 0.150 to 0.450 mm, powdery chitosan may be included in an amount within the range of 2.6 to 6.0% by weight.
상기 용매는 물; 또는 글리콜릭산, 젖산, 락틱산, 시트릭산, 사과산, 주석산, 구연산, 아스코르빅산(비타민 C), 아스코르빌포스페이트, 아스코르빌글루코사이드, 마그네슘아스코르빌포스페이트, 소디움아스코르빌포스페이트, 아스코르빌팔미테이트 및 이들 중 2이상의 혼합물로 이루어지는 군으로부터 선택되는 pH조절제가 용해된 산성수;일 수 있다. The solvent is water; Or glycolic acid, lactic acid, lactic acid, citric acid, malic acid, tartaric acid, citric acid, ascorbic acid (vitamin C), ascorbyl phosphate, ascorbyl glucoside, magnesium ascorbyl phosphate, sodium ascorbyl phosphate, ascorbic Acid may be dissolved in a pH adjuster selected from the group consisting of bilpalmitate and a mixture of two or more thereof.
본 발명에 따르면, 속용성을 갖는 키토산을 미용해 상태로 포함하며, 사용 직전에 사용자에 의해 용해시켜 사용토록 함으로써 피부에 부담 내지는 악영향을 줄 수 있는 방부제와 계면활성제 등을 포함하지 않으며, 피부 리프팅용으로 적절한 화장조성물을 제공함으로써 종래 기술에서의 문제점들로 지적된 화학 방부제의 위험성, 특히 피부 트러블 등을 예방할 수 있고, 피부에 안전한 천연물질을 그 원료물질의 성질을 이용하여 사용 시 즉석에서 화장품을 제조하여 가장 신선하게 원료물질의 효능 효과를 피부에 적용시킬 수 있도록 하는 효과가 제공된다.According to the present invention, it contains chitosan having a fast solubility in a state of beauty, and does not include preservatives and surfactants that can burden or adversely affect the skin by dissolving it by the user immediately before use, and lifting the skin. By providing a suitable cosmetic composition for the use, it is possible to prevent the danger of chemical preservatives, especially skin troubles, which are pointed out as problems in the prior art, and to use cosmetics immediately when using natural materials that are safe for the skin by using the properties of the raw materials. It is prepared to provide the effect of allowing the skin to apply the efficacy effect of the raw material to the freshest.
도 1 내지 도 6은 본 발명에서 사용되는 키토산, 특히 섬유상 키토산 및 분말상 키토산의 굵기에 따른 용해도 시험에 사용된 섬유상 키토산을 촬영한 사진들이다.1 to 6 are photographs of the fibrous chitosan used in the solubility test according to the thickness of chitosan, in particular fibrous chitosan and powdery chitosan, used in the present invention.
도 7은 탈아세틸화도의 증가에 따른 용해도 실험결과를 나타낸 사진이다.7 is a photograph showing the results of solubility experiment with increasing deacetylation degree.
도 8은 키토산 용액을 냉장보관하여 30일 경과 후의 상태를 나타낸 사진이다.8 is a photograph showing the state after 30 days elapsed by storing the chitosan solution refrigerated.
도 9는 키토산 용액을 상온에서 보관하여 10일 경과 후 곰팡이균이 착생되어 성장한 상태를 나타낸 사진이다.9 is a photograph showing a state in which the fungus bacteria cultivated after 10 days by storing the chitosan solution at room temperature.
도 10 내지 도 16은 각 주름 부위의 리프팅 수치 변화를 확인하기 위하여 사용 전, 사용 2주 후의 눈꼬리 리프팅 각도의 측정 데이터 값을 나타낸 그래프이다.10 to 16 are graphs showing measurement data values of the eye tail lifting angle before use and after 2 weeks of use, in order to confirm the lifting value change of each wrinkle area.
본 발명에 따른 최선의 형태는, 속용성을 갖는 키토산을 포함하는 피부 리프팅용 화장조성물은, 80 내지 100%의 범위 이내의 탈아세틸화도(DA: Degree of Deacetylation) 및 3.5 내지 7.5의 범위 이내의 pH를 갖는 용매에서 1 내지 15분의 범위 이내의 용해속도로 용해되는 속용성을 갖는 키토산 0.5 내지 6.0중량%; 및 잔량으로서 3.5 내지 7.5의 범위 이내의 pH를 갖는 용매;를 포함하되, 상기 키토산이 상기 용매로부터 물리적으로 분리되어 용해되어 있지 않은 상태로 포함됨을 특징으로 한다.In the best form according to the present invention, the cosmetic composition for skin lifting comprising chitosan having rapid solubility has a degree of deacetylation (DA) within the range of 80 to 100% and within the range of 3.5 to 7.5. 0.5 to 6.0% by weight of chitosan having a fast solubility dissolved in a solvent having a pH at a dissolution rate within a range of 1 to 15 minutes; And a solvent having a pH within a range of 3.5 to 7.5 as a residual amount, wherein the chitosan is physically separated from the solvent and is not dissolved therein.
이하, 본 발명을 구체적인 실시예를 참조하여 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to specific examples.
본 발명에 따른 속용성을 갖는 키토산을 포함하는 피부 리프팅용 화장조성물은, 80 내지 100%의 범위 이내의 탈아세틸화도(DA: Degree of Deacetylation) 및 3.5 내지 7.5의 범위 이내의 pH를 갖는 용매에서 1 내지 15분의 범위 이내의 용해속도로 용해되는 속용성을 갖는 키토산 0.5 내지 6.0중량%; 및 잔량으로서 3.5 내지 7.5의 범위 이내의 pH를 갖는 용매;를 포함하되, 상기 키토산이 상기 용매로부터 물리적으로 분리되어 용해되어 있지 않은 상태로 포함됨을 특징으로 한다.The cosmetic composition for skin lifting comprising chitosan having a fast dissolving property according to the present invention is a solvent having a degree of deacetylation (DA) within a range of 80 to 100% and a pH within a range of 3.5 to 7.5. 0.5 to 6.0 wt% of chitosan having a fast solubility dissolved at a dissolution rate within a range of 1 to 15 minutes; And a solvent having a pH within a range of 3.5 to 7.5 as a residual amount, wherein the chitosan is physically separated from the solvent and is not dissolved therein.
본 발명에서 키토산이라 함은 물 및/또는 pH가 산성의 범위 이내이며, 물을 기본으로 하여 물에 산성 물질을 포함시켜 수득되는 산성수에 용해되는 키토산을 의미하는 것으로 정의된다.In the present invention, the term chitosan is defined as meaning chitosan having water and / or pH within an acidic range and dissolved in acidic water obtained by including an acidic substance in water based on water.
상기 키토산은 바람직하게는 90 내지 100%의 범위 이내, 보다 바람직하게는 95 내지 100%의 범위 이내의 탈아세틸화도를 갖는 것일 수 있다.The chitosan may preferably have a degree of deacetylation within the range of 90 to 100%, more preferably within the range of 95 to 100%.
상기 키토산의 원료가 되는 키토산은 갑각류의 껍질에서 수득되는 키틴을 탈아세틸화시켜 얻은 탈아세틸화 산물이며, 물, 특히 약산에 용해되고, 인체에 잘 흡수되는 것으로서, 본 발명에서 사용되는 천연물질 원료의 하나이며, 피부에 적용될 때 피부 리프팅 효과를 부여하는 일 성분으로 기능한다. 키토산은 새우, 게, 곤충의 껍질, 오징어 뼈 등 갑각류에 많이 함유되어 있으며, 키틴을 알칼리 처리하여 얻는 글루코사민중합체이다. 주성분은 폴리글루코사민으로 고분자 구조의 무색 비결정성 분말이다. 글루코사민 결합으로 되어 있는 키토산은 그 분자구조가 우리 인체조직과 매우 유사한 구조를 이루고 있고, 인체 친화성이 매우 우수하여 면역반응이 일어나지 않기 때문에 식의약품으로 매우 귀중한 생체재료이다. 키토산의 탈아세틸화도는 문헌[참조: K. Toei 및 T. Kohara, Analytica Chimica Acta, 83, 59-65(1976)]에 기재된 바대로 콜로이드 적정을 사용하여 측정할 수 있다. Chitosan, which is a raw material of chitosan, is a deacetylated product obtained by deacetylating chitin obtained from shells of crustaceans, and is soluble in water, in particular weak acids, and is easily absorbed by the human body. It is one of and functions as one ingredient that gives skin lifting effect when applied to the skin. Chitosan is a glucosamine polymer obtained by alkali treatment of chitin, which is found in shellfish such as shrimp, crabs, insect shells, and squid bones. The main component is polyglucosamine, a colorless amorphous powder with a polymer structure. Chitosan, which is a glucosamine bond, has a molecular structure very similar to that of our human tissues, and is very valuable as a food and drug because it has a very good human affinity and no immune response occurs. The degree of deacetylation of chitosan can be measured using colloid titration as described in K. Toei and T. Kohara, Analytica Chimica Acta, 83, 59-65 (1976).
상기 키토산은 80 내지 100%의 범위 이내, 바람직하게는 90 내지 100%의 범위 이내, 보다 바람직하게는 95 내지 100%의 범위 이내의 탈아세틸화도를 갖는 것일 수 있다. 상기 탈아세틸화도가 80% 미만으로 되는 경우, 키토산의 용해도가 저하될 뿐만 아니라 미용해되어 잔류하는 고형분이 많아져서 피부에 도포 내지는 적용하기에 부적절하고, 중금속(납, 크롬, 카드뮴 등)과 같은 유해물 및 다른 불순물들이 잔류하여 피부에 좋지 않은 영향을 주는 문제점이 있을 수 있다.The chitosan may have a degree of deacetylation within the range of 80 to 100%, preferably within the range of 90 to 100%, more preferably within the range of 95 to 100%. When the deacetylation degree is less than 80%, not only the solubility of chitosan decreases but also the amount of undissolved solids increases, which is not suitable for application or application to the skin, such as heavy metals (lead, chromium, cadmium, etc.). There may be a problem that harmful substances and other impurities remain to adversely affect the skin.
상기 섬유상 키토산은 0.010 내지 0.050㎜의 범위 이내, 바람직하게는 0.015 이내 0.040㎜의 범위 이내의 평균굵기를 갖는 것일 수 있다. 상기 섬유상 키토산의 평균굵기가 0.010㎜ 미만으로 되는 경우, 용해속도는 빨라질 수 있으나, 섬유상으로의 제조 및 제조 후 취급이 복잡하거나 어려워지는 문제점이 있을 수 있고, 반대로 0.050㎜를 초과하는 경우, 용해속도가 늦어 속용성의 특성이 사라지고, 사용 직전에 사용자에 의해 용해시켜 사용하는 것이 불편하게 되는 문제점이 있을 수 있다. 섬유상 키토산은 1.7 내지 4.0중량%의 범위 이내의 양으로 포함될 수 있다.The fibrous chitosan may have an average thickness within the range of 0.010 to 0.050 mm, preferably within the range of 0.015 to 0.040 mm. When the average thickness of the fibrous chitosan is less than 0.010 mm, the dissolution rate may be increased, but there may be a problem in that the handling and manufacturing of the fibrous form is complicated or difficult, and on the contrary, when the average thickness of the fibrous chitosan exceeds 0.050 mm, the dissolution rate There is a problem that the property of the fast solubility disappears late, and it becomes inconvenient to dissolve and use by the user immediately before use. Fibrous chitosan may be included in amounts within the range of 1.7 to 4.0 weight percent.
상기 키토산은 0.150 내지 0.450㎜의 범위 이내, 바람직하게는 0.190 내지 0.400㎜의 범위 이내, 보다 바람직하게는 0.195 내지 0.395㎜의 범위 이내의 평균굵기를 갖는 분말상 키토산일 수 있으며, 분말상 키토산은 2.6 내지 6.0중량%의 범위 이내의 양으로 포함될 수 있다.The chitosan may be powdery chitosan having an average thickness within the range of 0.150 to 0.450 mm, preferably within the range of 0.190 to 0.400 mm, more preferably within the range of 0.195 to 0.395 mm, powdery chitosan is 2.6 to 6.0 It may be included in an amount within the range of weight percent.
상기 섬유상 키토산은 키토산을 산에 용해시키고, 교반시킨 후, 습식방사로 가공하여서 수득될 수 있다. 이때 가공 후, 세척 및 건조과정을 거치게 되면서 사용된 산은 제거되어 잔류하지 않고, 산의 사용에 의한 키토산이 염의 형태로 되어 용해도가 높아진다.The fibrous chitosan can be obtained by dissolving chitosan in acid, stirring and processing by wet spinning. At this time, after the processing, washing and drying process, the used acid is removed and does not remain, so that the solubility of chitosan by the use of the acid in the form of salt increases.
상기 분말상 키토산은 키토산을 분쇄시켜 수득될 수 있으며, 역시 염의 형태로서 용해도가 증가된다.The powdery chitosan can be obtained by grinding the chitosan, which also increases the solubility in the form of a salt.
상기 키토산은 3.5 내지 7.5의 범위 이내의 pH를 갖는 용매에서 1 내지 15분의 범위 이내, 바람직하게는 5 내지 10분의 범위 이내에서 용해되는 용해속도를 갖는 것일 수 있다. 상기 용해속도가 1분 미만인 경우, 특별한 문제점은 없으나, 용해속도를 높이기 위하여 키토산의 제조에 많은 노력과 시간이 요구되어 생산성이 저하되는 문제점이 있을 수 있고, 반대로 15분을 초과하는 것은 사용 직전에 사용자에 의해 용해시켜 사용하는 것이 불편하게 되는 문제점이 있을 수 있다. The chitosan may have a dissolution rate dissolved in a solvent having a pH within the range of 3.5 to 7.5 within 1 to 15 minutes, preferably within the range of 5 to 10 minutes. If the dissolution rate is less than 1 minute, there is no particular problem, but in order to increase the dissolution rate requires a lot of effort and time in the production of chitosan, there may be a problem that the productivity is lowered, on the contrary exceeding 15 minutes immediately before use There may be a problem that it is inconvenient to dissolve and use by the user.
또한, 상기한 용해속도는 일반적으로 여성이 세안을 하는 시간 범위인 10 내지 15분에 맞춰 조정한 것으로서, 세안 전 혼합, 용해시키고, 세안 후 사용하도록 의도된 것이다. 또한 상기 키토산은 본 발명에 따른 화장조성물 총 중량으로 기준으로 0.5 내지 6.0중량%의 범위 이내, 바람직하게는 0.9 내지 1.4중량%의 범위 이내의 양으로 포함될 수 있다. 상기 키토산의 함량이 0.5중량% 미만으로 되는 경우, 상기 키토산을 상기 용매에 용해시켜 수득되는 키토산 용액의 점도가 너무 낮아 피부 리프팅 효과가 저하되고, 소비자의 만족도가 저하되는 등의 문제점이 있을 수 있고, 반대로 6.0중량%를 초과하는 경우, 수득되는 키토산 용액의 점도가 너무 높아 피부에의 적용이 어렵거나 불편하여 역시 소비자의 만족도가 저하되는 등의 문제점이 있을 수 있다.In addition, the above dissolution rate is generally adjusted to 10 to 15 minutes, which is a time range during which women wash face, and is intended to be mixed, dissolved, and used after cleansing before washing. In addition, the chitosan may be included in an amount within the range of 0.5 to 6.0% by weight, preferably 0.9 to 1.4% by weight based on the total weight of the cosmetic composition according to the present invention. When the content of the chitosan is less than 0.5% by weight, the chitosan solution obtained by dissolving the chitosan in the solvent is too low, the skin lifting effect is lowered, there may be a problem such as lowering the customer satisfaction On the contrary, if it exceeds 6.0% by weight, the viscosity of the obtained chitosan solution is too high, it is difficult or inconvenient to apply to the skin may also have a problem such as lowering the customer satisfaction.
상기 용매는 본 발명에 따른 화장조성물에서 상기 키토산과 분리된 상태로 존재하다가 사용 직전 사용자에 의해 상기 키토산을 용해시켜 키토산을 피부에 용이하게 적용시키도록 하는 기능을 한다. 키토산은 건조된 고체 상태에서는 상온에서 거의 부패하거나 변성되지 않으나, 일단 용해되어 용액 상태가 되면 상온에서도 쉽게 부패하고, 곰팡이 등이 생장하기 좋은 상태가 되기 때문에 액상의 키토산 제품의 경우, 방부제 등의 첨가가 필수적이나, 본 발명에서는 키토산이 건조한 고체상태로 유지되도록 함으로써 방부제의 사용을 피할 수 있도록 한 점에 특징이 있다. 또한, 키토산의 특성 상 용매에 용해된 후에는 시간의 경과에 따라 분자구조가 분해되어 저분자량화 되며, 따라서 경시적으로 점도가 저하되게 되며, 점도의 저하는 피부에의 적용 시 리프팅 효과의 감소를 야기할 수 있으나, 본 발명에서는 키토산을 건조한 고체상태로 유지하다가 사용 직전에 용매에 용해시켜 사용토록 함으로써 분해가 거의 없는 높은 점도를 갖는 키토산 용액을 피부에 즉시로 적용시키는 것을 가능하게 하여 특히 리프팅 효과가 뛰어난 화장조성물을 제공할 수 있다. 상기 용매는 3.5 내지 7.5의 범위 이내, 바람직하게는 5 내지 7의 범위 이내의 pH를 가질 수 있다. 상기 용매의 pH가 3.5 미만으로 되는 경우, 산성이 너무 강하여 피부에 자극 내지는 손상을 가할 수 있어 화장용으로 적절치 못하게 되는 문제점이 있을 수 있고, 7.5를 초과하는 경우, 키토산이 용해되지 않거나 또는 용해속도가 너무 느려져서 사용 직전에 사용자에 의해 용해시켜 사용하는 것이 불편하게 되는 문제점이 있을 수 있다.The solvent is present in the cosmetic composition according to the present invention in a state separated from the chitosan and functions to facilitate the application of chitosan to the skin by dissolving the chitosan by the user immediately before use. Chitosan hardly decomposes or denatures at room temperature in the dried solid state, but once dissolved and in solution, it easily decomposes at room temperature, and molds grow well. However, the present invention is characterized in that the chitosan is kept in a dry solid state, thereby avoiding the use of a preservative. In addition, after dissolving in a solvent due to the nature of chitosan, the molecular structure decomposes over time, resulting in low molecular weight, and thus viscosity decreases with time, and the decrease in viscosity decreases the lifting effect when applied to the skin. However, in the present invention, the chitosan is kept in a dry solid state and dissolved in a solvent immediately before use, so that the chitosan solution having a high viscosity with almost no decomposition can be applied immediately to the skin. A cosmetic composition with excellent effect can be provided. The solvent may have a pH within the range of 3.5 to 7.5, preferably within the range of 5 to 7. If the pH of the solvent is less than 3.5, there is a problem that the acidity is too strong may cause irritation or damage to the skin, which is not suitable for cosmetic use, if it exceeds 7.5, chitosan is not dissolved or dissolution rate There may be a problem that is too slow to be dissolved by the user immediately before use is inconvenient to use.
상기 용매는 물; 또는 글리콜릭산, 젖산, 락틱산, 시트릭산, 사과산, 주석산, 구연산, 아스코르빅산(비타민 C), 아스코르빌포스페이트, 아스코르빌글루코사이드, 마그네슘아스코르빌포스페이트, 소디움아스코르빌포스페이트, 아스코르빌팔미테이트 및 이들 중 2이상의 혼합물로 이루어지는 군으로부터 선택되는 pH조절제가 용해된 산성수;일 수 있다.The solvent is water; Or glycolic acid, lactic acid, lactic acid, citric acid, malic acid, tartaric acid, citric acid, ascorbic acid (vitamin C), ascorbyl phosphate, ascorbyl glucoside, magnesium ascorbyl phosphate, sodium ascorbyl phosphate, ascorbic Acid may be dissolved in a pH adjuster selected from the group consisting of bilpalmitate and a mixture of two or more thereof.
선택적으로 상기 물은 후로랄워터, 암반수, 해양심층수, 미네랄워터, 황토지장수, 죽염정제수, 인삼수, 홍삼수, 인삼열매수, 광천수, 탄산수, 게르마늄수, 베리류 함유 물, 광물질 함유 물 및 이들 중 2이상의 혼합물로 이루어지는 군으로부터 선택된 것일 수 있다.Optionally, the water may be fresh water, rock water, deep sea water, mineral water, loess longevity, bamboo salt purified water, ginseng water, red ginseng water, ginseng fruit water, mineral water, carbonated water, germanium water, berry-containing water, mineral-containing water, and two or more of them. It may be selected from the group consisting of a mixture.
상기 화장품은 제품의 특성에 따라 알부틴, 아데노신 등의 기능성 원료, 녹차 또는 녹차추출물 등의 다양한 천연원료를 더 첨가할 수 있다.The cosmetics may be further added to various natural raw materials such as functional raw materials, such as arbutin, adenosine, green tea or green tea extract, depending on the characteristics of the product.
상기한 바와 같은 구성 상의 특징을 갖는 본 발명에 따른 속용성을 갖는 키토산을 포함하는 피부 리프팅용 화장조성물은 속용성의 특성을 갖는 키토산을 상기 키토산을 빠르게 용해시키기에 적절한 용매를 포함하며, 사용 직전에 사용자가 상기 키토산을 상기 용매에 용해시킨 후, 바로 사용하는 것을 가능하게 하며, 그러한 구성 상의 특징에 따라 종래의 키토산 함유 화장품과는 달리 방부제 및 계면활성제 등 합성 첨가물들을 사용치 않고도, 제조 후의 보관, 유통이 용이하다는 잇점을 가지면서도 동시에 방부제 및 계면활성제 등을 포함하지 않으면서도 장기 보관이 가능하며, 장기 보관에도 불구하고 키토산의 물성에 변화가 없고, 사용 직전에 사용자가 상기 키토산을 용해시킨 후, 바로 사용할 수 있도록 함으로써 방부제나 계면활성제 등의 합성 첨가물의 유해성을 겪지 않고도 신선하고 원래의 효능을 유지할 수 있는 함키토산 화장조성물을 피부에 사용이 가능하며, 특히 키토산을 용매에 용해시킨 직후에 높은 점도를 나타내는 키토산 용액을 피부에 도포 등의 방법으로 적용시키는 것에 의하여 특히 피부 리프팅 효과를 기대할 수 있다.The cosmetic composition for skin lifting comprising a quick-release chitosan according to the present invention having the configuration features as described above comprises a solvent suitable for rapidly dissolving the chitosan with a quick-to-use property, and immediately before use. It allows the user to immediately use the chitosan after dissolving it in the solvent, and according to such configuration features, unlike conventional chitosan-containing cosmetics, it is stored after preparation without using synthetic additives such as preservatives and surfactants. It has the advantage of easy distribution and at the same time, it can be stored for a long time without including preservatives and surfactants, and there is no change in the physical properties of chitosan despite long-term storage, and the user dissolves the chitosan immediately before use. Synthesis of preservatives and surfactants It is possible to use the Hamchitosan cosmetic composition which can maintain fresh and original efficacy without suffering from the harmful effects of the false substances, especially by applying chitosan solution that shows high viscosity to the skin immediately after dissolving chitosan in a solvent. By application, skin lifting effects can be expected in particular.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예들은 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로서, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예들에 의해 제한되지 않는다는 것은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These embodiments are only for explaining the present invention in more detail, and the scope of the present invention is not limited by these embodiments in accordance with the gist of the present invention, those skilled in the art. It will be obvious to
실험예 1: 키토산의 굵기에 따른 용해도 시험Experimental Example 1: Solubility test according to the thickness of chitosan
각각 서로 다른 평균굵기를 갖는 것을 제외하고는 동일한 탈아세틸화도(90%)를 갖는 분말상 키토산 또는 섬유상 키토산(키토산 만을 사용하여 제조)들을 사용하여 고형분이 육안으로 보이지 않을 때까지 또는 더 이상의 용해상태의 변화가 보이지 않을 때까지의 시간을 용해시간으로 하여 용해시간을 측정하였다. 이때 사용된 용매는 글리콜릭산을 물에 용해시켜 수득된 pH 4의 산성수이었으며(섬유상 키토산 1.2중량%, 산성수 98.8중량%), 섬유상 키토산의 굵기 측정에 사용된 기기는 e Scope Professional PRO(제조회사명: 중국 소재 오이테즈사(OiTEZ))이었고, 배율은 500배로 하였다.Powdered chitosan or fibrous chitosan (prepared using chitosan only) with the same degree of deacetylation (90%) except that each had a different average thickness until solids were not visible or further dissolved The dissolution time was measured using the time until no change was seen as the dissolution time. The solvent used was acidic water of pH 4 obtained by dissolving glycolic acid in water (1.2 wt% fibrous chitosan, 98.8 wt% acidic water), and the instrument used for measuring the thickness of fibrous chitosan was manufactured by e Scope Professional PRO (manufactured by Company name: OiTEZ Co., Ltd. in China, and the magnification was 500 times.
도 1의 섬유상 키토산은 0.0153㎜의 평균두께를 가졌으며, 용해시간은 약 7분이었다.Fibrous chitosan of FIG. 1 had an average thickness of 0.0153 mm, and a dissolution time was about 7 minutes.
도 2의 섬유상 키토산은 0.0215㎜의 평균두께를 가졌으며, 용해시간은 약 9분이었다.Fibrous chitosan in FIG. 2 had an average thickness of 0.0215 mm, and the dissolution time was about 9 minutes.
도 3의 섬유상 키토산은 0.03979㎜의 평균두께를 가졌으며, 용해시간은 약 13분이었다.Fibrous chitosan in FIG. 3 had an average thickness of 0.03979 mm, and the dissolution time was about 13 minutes.
도 4의 섬유상 키토산은 0.2697㎜의 평균두께를 가졌으며, 1시간 이내 완전용해가 불가능한 것으로 나타났다.Fibrous chitosan of FIG. 4 had an average thickness of 0.2697 mm and was found to be impossible to dissolve completely within 1 hour.
도 5의 분말상 키토산은 각각 0.332386㎜, 0.195323㎜ 및 0.350297㎜의 평균입경을 갖는 것으로 나타났다.The powdery chitosan of FIG. 5 was found to have an average particle diameter of 0.332386 mm, 0.195323 mm and 0.350297 mm, respectively.
도 6의 분말상 키토산은 각각 0.296869㎜, 0.390526㎜ 및 0.222697㎜의 평균입경을 갖는 것으로 나타났다.The powdery chitosan of FIG. 6 was found to have an average particle diameter of 0.296869 mm, 0.390526 mm and 0.222697 mm, respectively.
실험예 2: 섬유상 키토산의 탈아세틸화도에 따른 용해도 시험Experimental Example 2: Solubility test according to deacetylation degree of fibrous chitosan
각각 서로 다른 탈아세틸화도를 갖는 것을 제외하고는 동일한 굵기(0.025㎜)를 갖는 섬유상 원사(키토산 만을 사용하여 제조)들을 사용하여 용해도를 측정하였다. 이때 사용된 용매는 글리콜릭산을 물에 용해시켜 수득된 pH 4의 산성수이었으며(섬유상 키토산 1.2중량%, 산성수 98.8중량%), 용해도 실험의 결과를 도 7의 사진으로 나타내었다.Solubility was measured using fibrous yarns (manufactured using chitosan only) having the same thickness (0.025 mm) except that each had a different degree of deacetylation. The solvent used was acidic water of pH 4 obtained by dissolving glycolic acid in water (1.2% by weight of fibrous chitosan, 98.8% by weight of acidic water), and the results of the solubility experiment are shown in the photograph of FIG. 7.
도 7에 나타난 바와 같이, 탈아세틸화도의 증가에 따라 용해도가 증가되는 일관된 경향을 보임을 확인할 수 있었다. 특히, 탈아세틸화도 70% 및 75%의 경우, 피부에 도포하기 곤란한 정도로 미용해된 고형분이 육안으로도 크게 보일 정도로 용해도가 낮음을 확인할 수 있었으며, 이에 비해 80% 내지 90%에서는 육안으로는 고형분이 보이나 화장품의 용도로 사용할 수는 있을 정도의 용해도를 나타내었으며, 90% 이상에서는 미용해된 고형분이 육안으로는 확인되지 않을 정도로 높은 용해도를 나타냄을 확인할 수 있었다.As shown in FIG. 7, it was confirmed that the solubility increased with increasing deacetylation degree. In particular, in the case of deacetylation degree of 70% and 75%, it was confirmed that the solubility was so low that the cosmetically solid content that was difficult to apply to the skin was largely visible to the naked eye, whereas in 80% to 90%, the solid content was visually It showed solubility that can be used for the purpose of this show or cosmetics, and it was confirmed that at 90% or more, the undissolved solids exhibited high solubility that cannot be seen with the naked eye.
실험예 3: 키토산으로 제조된 섬유상 키토산과 분말상 키토산의 함량에 따른 용해시간 및 수득되는 키토산 용액의 물성 측정 시험Experimental Example 3: Test for measuring the physical properties of the obtained chitosan solution and dissolution time according to the content of fibrous chitosan and powdery chitosan prepared from chitosan
상기 실험예 1 및 2들에 기초하여 탈아세틸화도 95%의 키토산을 사용하여 분말상 키토산과 섬유상 키토산을 제조하여 용해도 및 용해 후 수득되는 키토산 용액의 물성을 측정하였으며, 그 결과를 하기 표 1(표 1-1 내지 표 1-6)에 나타내었다. 이때, 분말상 키토산은 평균입경 0.298㎜이었고, 섬유상 키토산은 평균굵기 0.025㎜이었으며, 용매로는 정제수 또는 글리콜릭산으로 pH를 조정한 pH 4의 산성수를 사용하였다. 점도의 측정은 실온(25℃)에서 수행하였다. 하기 표 1에서 키토산 불용성은 중성인 물에 불용성이고, 산성수(AHA산으로서는 글리콜릭산을 사용)에 용해되는 것을 의미하고, 분말은 분말상으로, 원사는 섬유상으로 만든 것을 의미한다. 또한, 하기 표 1에서 키토산 수용성은 중성인 물에 가용성임을 의미하고, 분말은 분말상으로, 원사는 섬유상으로 만든 것을 의미한다.Based on Experimental Examples 1 and 2, powdery chitosan and fibrous chitosan were prepared using chitosan having a deacetylation degree of 95%, and the physical properties of the chitosan solution obtained after solubility and dissolution were measured. 1-1 to Table 1-6). At this time, the powdery chitosan was an average particle diameter of 0.298mm, the fibrous chitosan was an average thickness of 0.025mm, and the acidic water of pH 4 adjusted to pH with purified water or glycolic acid was used as a solvent. The measurement of the viscosity was performed at room temperature (25 ° C). In Table 1, chitosan insoluble means that it is insoluble in neutral water and dissolved in acidic water (glycolic acid is used as AHA acid), and the powder is powdered, and the yarn is made in fibrous form. In addition, in the following Table 1, chitosan water solubility means that it is soluble in neutral water, and the powder is powder, meaning that the yarn is made of fibrous.
[표 1-1]Table 1-1
Figure PCTKR2015004872-appb-I000001
Figure PCTKR2015004872-appb-I000001
[표 1-2]TABLE 1-2
Figure PCTKR2015004872-appb-I000002
Figure PCTKR2015004872-appb-I000002
[표 1-3]Table 1-3
Figure PCTKR2015004872-appb-I000003
Figure PCTKR2015004872-appb-I000003
[표 1-4]Table 1-4
Figure PCTKR2015004872-appb-I000004
Figure PCTKR2015004872-appb-I000004
[표 1-5]Table 1-5
Figure PCTKR2015004872-appb-I000005
Figure PCTKR2015004872-appb-I000005
[표 1-6]Table 1-6
Figure PCTKR2015004872-appb-I000006
Figure PCTKR2015004872-appb-I000006
상기 표 1에 나타난 실험결과 중 용해시간과 관련하여서는 화장품이 일상적인 환경 하에서 사용된다는 것을 전제로 하여 온도를 제어하지 않고, 랜덤한 온도에서 측정한 바에 기인하는 것으로 여겨지며, 다소간의 실험실에서 있을 수 있는 측정오차에 대해서는 규명하지 않았다. 용해시간은 다소 불규칙하기는 하나, 분말상 키토산과 섬유상 키토산 공히 전반적으로 투입량의 증가에 따라 증가하는 경향을 나타내나, 섬유상 키토산의 용해시간이 더 증가하는 경향을 나타냄을 확인할 수 있었다. 이는 형상에 따른 표면적 등에서의 차이로 인한 것으로 고려된다.In relation to the dissolution time of the experimental results shown in Table 1, it is assumed that the cosmetics are used under ordinary conditions and do not control the temperature, and are believed to be due to the measurement at a random temperature. No measurement error was identified. Although the dissolution time was somewhat irregular, both powdery chitosan and fibrous chitosan showed a tendency to increase as the overall input amount increased, but it was confirmed that the dissolution time of fibrous chitosan further increased. This is considered to be due to the difference in surface area and the like depending on the shape.
상기 표 1에 나타난 실험결과 중 pH와 관련하여서는 다소의 측정오차를 고려하면 분말상 키토산과 섬유상 키토산의 투입량의 증가에 따라 pH가 일관되게 감소하는 경향을 나타내나, 섬유상 키토산에서의 pH의 감소가 덜 감소하는 경향을 나타냄을 확인할 수 있었다.Considering some measurement errors in relation to the pH of the experimental results shown in Table 1, the pH tends to decrease consistently with the increase in the amount of powdery chitosan and fibrous chitosan, but less decrease in pH in the fibrous chitosan. It can be seen that the tendency to decrease.
상기 표 1에 나타난 실험결과 중 특히 본 발명이 목적하는 바와 밀접한 연관이 있는 점도와 관련하여서는 분말상 키토산과 섬유상 키토산 공히 투입량의 증가에 따라 점도가 일관되게 증가하는 경향을 나타내나, 특히 본 발명에 따른 섬유상 키토산이 더 높은 점도를 나타내었고, 특히 투입량이 증가함에 따라 섬유상 키토산이 분말상 키토산에 비하여 점도의 증가폭이 훨씬 크게 나타남을 확인할 수 있었다.Among the experimental results shown in Table 1 above, in particular, in relation to the viscosity closely related to the purpose of the present invention, both the powdery chitosan and the fibrous chitosan showed a tendency to increase the viscosity consistently with the increase in the amount, in particular according to the present invention. Fibrous chitosan showed a higher viscosity, and as the dosage increased, fibrous chitosan showed a much greater increase in viscosity compared to powdery chitosan.
실험예 4: 키토산 용액의 보관 시험Experimental Example 4: Storage test of chitosan solution
상기 실험예들에서 사용된 바의 탈아세틸화도 95%인 키토산 1.2중량%를 98.8%의 정제수에 용해시켜 수득된 키토산 용액을 보관할 때의 변화를 시험하였다.The change in storing the chitosan solution obtained by dissolving 1.2% by weight of chitosan having a deacetylation degree of 95% as used in the above experimental examples in 98.8% purified water was tested.
도 8에 나타난 바와 같이, 상기 키토산 용액을 냉장보관(평균 냉장 온도: 4 내지 -5℃)하는 경우, 냉장보관 30일 경과 후에도 곰팡이균이 발생하지 않았으나, 도 9에 나타난 바와 같이, 상온(평균 온도: 25℃) 보관의 경우, 상온보관 10일 경과 시 곰팡이균이 착생되어 성장함을 확인할 수 있었다.As shown in FIG. 8, when the chitosan solution was refrigerated (average refrigeration temperature: 4 to -5 ° C.), fungi did not occur even after 30 days of refrigeration, but as shown in FIG. Temperature: 25 ℃) In the case of storage, it was confirmed that the fungus bacteria grow and grow after 10 days at room temperature storage.
실험예 5: 연령별 선호도 관련 관능 시험Experimental Example 5: Sensory Test Related to Age Preference
0.5중량% 내지 2.0중량%(잔량은 상기 실험예들에서 사용된 산성수)의 농도별 키토산 용액들을 준비하고, 20대에서 50대까지의 성인 여성들을 각 연령대 별(즉, 20대, 30대, 40대 및 50대)로 30인씩 총 120인으로 이루어지는 패널을 구성하고, 각 패널에게 각 농도별 키토산 용액들(총 16종)을 모두 지급하고, 1개월 간 임의로 사용토록 한 후, 1개월 경과 시점에서 가장 좋아하는 농도의 키토산 용액을 체크하도록 하는 선호도 관능 시험을 수행하고, 그 결과를 하기 표 2에 나타내었다. 실험의 공정성을 위하여 각 농도별 키토산 용액들은 농도별로 0.5중량% 내지 2.0중량%의 범위에서 0.5중량%부터 0.1중량%씩 증분시키는 방식으로 키토산 용액들을 준비하고, 준비된 키토산 용액들은 낮은 농도에서 높은 농도로 순차적으로 영문 알파벳(A 내지 P)들을 할당 표기하여 패널에게 제공하였다.Prepare chitosan solutions by concentration of 0.5% to 2.0% by weight (the remaining amount is acidic water used in the above experiments), and adult women from 20s to 50s by age group (ie, 20s and 30s). , 40's and 50's) consisted of a total of 120 panels of 30 people, and each panel was provided with chitosan solutions for each concentration (total 16 species), and then randomly used for 1 month, and then 1 month. The preference sensory test was performed to check the chitosan solution of the most preferred concentration at the elapsed time point, and the results are shown in Table 2 below. For the fairness of the experiment, the chitosan solutions for each concentration were prepared by increasing the concentration of 0.5 to 0.1 wt% in the range of 0.5 wt% to 2.0 wt%, and the prepared chitosan solutions were prepared at low concentration and high concentration. English alphabets (A to P) were sequentially assigned to the panel and provided to the panel.
[표 2]TABLE 2
Figure PCTKR2015004872-appb-I000007
Figure PCTKR2015004872-appb-I000007
상기 표 2에 나타난 바와 같이, 키토산 농도가 0.9% 내지 1.3%의 범위 이내인 것이 전반적으로 선호도가 높았고, 특히 1.0% 내지 1.2%의 범위 이내가 상대적으로 더 높았으며, 1.1%와 1.2%가 상대적으로 매우 높았고, 그 중에서도 1.2% 농도가 가장 많이 선호되었으며, 특히 1.1중량% 농도는 20대 내지 40대에서 고르게 높았으나, 상대적으로 1.2중량%는 40대와 50대에서 특히 높았음을 확인할 수 있었다.As shown in Table 2, the chitosan concentration within the range of 0.9% to 1.3% was high overall preference, in particular within the range of 1.0% to 1.2% was relatively higher, 1.1% and 1.2% relative The concentration was very high, and among them, the concentration of 1.2% was the most preferred. Especially, the concentration of 1.1% by weight was evenly high in the 20s and 40s, but the relative 1.2% by weight was especially high in the 40s and 50s. .
실험예 6: 리프팅 효과 시험Experimental Example 6: Lifting Effect Test
상기 실험예들에 기초하여 탈아세틸화도 95%의 키토산을 사용하여 0.025㎜의 평균두께를 갖는 섬유상 키토산을 준비하고, 이를 글리콜릭산을 정제수에 용해시켜 pH 4의 산성수를 준비하고, 상기 산성수 98.8중량%에 상기 섬유상 키토산 1.2중량%를 용해시켜 화장조성물을 준비하고, 이를 리프팅 효과 실험에 사용하였다.Based on the above experimental examples, a fibrous chitosan having an average thickness of 0.025 mm was prepared using chitosan having a deacetylation degree of 95%, and glycolic acid was dissolved in purified water to prepare acidic water having a pH of 4, and the acidic water A cosmetic composition was prepared by dissolving 1.2% by weight of the fibrous chitosan in 98.8% by weight, which was used for a lifting effect experiment.
리프팅 효과 실험은 다음과 같이 수행하였다.Lifting effect experiments were performed as follows.
시험기간: 2015년 01월 08일~ 2015년 01월 23일Test Period: January 08, 2015-January 23, 2015
시험제품: 상기 기재의 화장조성물Test product: cosmetic composition of the above description
시험목적: 상기 기재의 화장조성물을 1주일에 1회 및 2주 사용 후 눈꼬리 리프팅, 입가 리프팅, 안면 처짐, 팔자 주름, 목주름, 수분량, 각질 개선에 대한 효과를 평가하고자 시행Purpose: To evaluate the effects of eyelid lifting, mouth lifting, facial sagging, nasolabial folds, neck wrinkles, moisture content, and keratin improvement after using the cosmetic composition described above once and twice a week
시험 대상자: 시험대상자 선정 및 제외기준을 만족하는 만 20 내지 55세의 여성Subjects: Women aged 20 to 55 who meet the subject selection and exclusion criteria
시험대상자 수: 21명Number of subjects: 21
시험대상자 선정기준: 다음의 선정기준에 적합 한 자Subject Selection Criteria: Those who meet the following criteria
1) 만 20 내지 55세의 성인 여성1) Adult women aged 20 to 55
2) 시험의 목적, 내용 등에 관하여 충분히 설명을 듣고 자발적으로 동의 서명한 자2) A person who has fully explained the purpose and contents of the examination and voluntarily signed the consent
3) 시험기간 동안 추적관찰이 가능한 자3) A person who can follow up during the trial period
4) 시험대상자 제외기준에 포함되지 않는 자4) Those who are not included in the subject exclusion criteria
시험대상자 선정제외기준: 다음의 제외기준 중 하나라도 해당되는 자는 본 시험에 참여할 수 없다.Exclusion Criteria for Subject Selection: Any one of the following exclusion criteria cannot participate in this test.
1) 본인이 원하지 않거나 동의서를 작성하지 않은 경우1) If you do not want or do not complete the consent form
2) 정신과적 질환이 있는 경우2) If you have a psychiatric illness
3) 감염성피부 질환이 있는 경우3) Infectious skin disease
4) 시험참가 시점 3개월 이내에 면역억제제 치료를 받은 경우4) In case of receiving immunosuppressive treatment within 3 months of participation
5) 시험참가 시점 1개월 이내에 전신 스테로이드 또는 광선치료를 받은 경우5) If systemic steroid or phototherapy was received within 1 month of participation
6) 시험 부위에 병변이 있어 측정이 곤란한 경우6) Difficult to measure due to lesion on test site
7) 아토피성 피부를 가진 경우7) If you have atopic skin
8) 화장품, 의약품 또는 일상적인 광 노출에 대한 반응이 심하거나 알러지가 있는 경우8) Severe or allergic reactions to cosmetics, medicine or routine light exposure
9) 시험참여 시점으로부터 3개월 이내에 피부 스켈링 또는 피부 관리를 받은 경우9) If you have skin skating or skin care within 3 months of participating
10) 임신 중이거나 수유중인 경우10) pregnant or lactating
11) 기타 위의 사항들 외에 책임연구자 또는 시험담당자의 판단으로 인체적용시험 수행이 곤란하다고 판단되는 경우11) In addition to the above, if the responsible researcher or the person in charge of the test determines that it is difficult to perform the human application test.
시험방법: 본 인체적용시험 참여에 동의하고, 선정기준 및 제외기준을 만족하는 시험대상자를 대상으로 시험제품을 2주간 사용하도록 하였다. 시험대상자는 방문 1에서 시험제품을 사용하였고, 제품 사용 전과 사용 직후 시험 부위를 평가하였다. 방문 2에서 제품 사용 2주 후 동일 시험 부위를 평가하였고 시험 종료 후 유효성 및 기호도 설문평가를 완료하였다.Test Method: Subjects who agreed to participate in the human body application test and met the selection criteria and exclusion criteria were to use the test product for 2 weeks. Subjects used the test product at visit 1 and evaluated the test site before and immediately after using the product. The same test site was evaluated two weeks after use of the product at visit 2, and the validity and preference questionnaire evaluation was completed after the end of the test.
평가항목: Evaluation item:
1) 기기적 평가1) Mechanical evaluation
- 피부(눈꼬리, 입가, 볼) 리프팅 측정 (F-ray)-Skin (eye, mouth, cheek) lifting measurement (F-ray)
- 피부 팔자 주름 측정 (Primos Pico)-Skin Pleated Wrinkle Measurement (Primos Pico)
- 피부 목 주름 측정 (Primos Pico)-Skin neck wrinkle measurement (Primos Pico)
- 피부 수분함유량 측정 (Corneometer)-Skin moisture content measurement (Corneometer)
- 피부 각질 측정 (Visioscan VC98)Skin keratin measurement (Visioscan VC98)
2) 유효성 평가 설문조사(Global Assessment of Efficacy):시험대상자 평가2) Global Assessment of Efficacy: Subject Evaluation
3) 안전성평가: 각 방문 시 시험제품 사용부위에 대한 연구자 육안평가 결과와 시험대상자 설문결과를 종합하여 연구자가 평가함3) Safety evaluation: The researcher evaluates the results of the researcher's visual evaluation and the subject's questionnaire on the site of the test product used at each visit.
기타 조사(관찰)항목: Other survey items:
1) 인구학적 조사 : 인체적용시험 시작 전 성별, 생년월일, 나이 조사1) Demographic survey: Survey of gender, date of birth and age before the start of human testing
2) 활력징후 조사 : 인체적용시험 시작 전 육안평가를 통한 신체검사2) Vital sign investigation: physical examination through visual evaluation before starting the human application test
3) 병력조사 : 인체적용시험 시작 전 주증상, 발병일, 검사 및 치료이력에 대하여 조사3) Medical history investigation: Investigate the main symptoms, the date of onset, examination and treatment history before the start of the human testing.
4) 제품기호도 조사 : 설문자료를 통한 제품의 기호도를 조사4) Product symbol survey: Survey of product symbol through survey data
방문일정: 2회 방문으로 함Visited: 2 visits
1) 방문 1: 시험대상자 동의, 시험대상자 선정검사, 제품 사용 전, 직후 측정, 제품 배부1) Visit 1: Subject acceptance, subject selection inspection, measurement before and after use of product, product distribution
2) 방문 2: 이상반응 확인, 제품 사용 2주 후 측정, 설문평가2) Visit 2: Confirmation of adverse reaction, measurement after 2 weeks of product use, survey evaluation
1차 유효성 평가 변수: 시험제품 사용 전 후 피부 눈꼬리 리프팅, 입가 리프팅, 볼 리프팅, 팔자주름, 목주름, 수분 함유량, 각질량에 대한 측정값Primary efficacy evaluation variables: measurement of skin crow's feet, mouth lifting, ball lifting, nasolabial folds, neck wrinkles, moisture content, and angular mass before and after using the test product
2차 유효성 평가 변수: 유효성 평가 설문조사(Global Assessment of Efficacy) 결과 Secondary Validation Variables: Results of the Global Assessment of Efficacy
안전성 평가: 시험제품 사용 후 나타나는 이상증상에 대하여 평가한다.Safety Assessment: Evaluate abnormal symptoms after use of the test product.
평가부위 및 측정 방법: 기기적 평가를 위하여 시험대상자는 실내온도 20 내지 25, 습도 40 내지 60%의 항온항습 조건의 대기실에서 30분간 안정을 취하여 피부표면 온도와 습도를 측정공간의 환경에 적응하게 하였으며, 안정을 취하는 동안에는 수분 섭취를 제한하였다. 객관적 측정을 위하여 연구자 1인이 측정하였으며, 매 측정 시 동일한 부위를 측정하였다.Evaluation site and measuring method: For mechanical evaluation, the test subject is allowed to settle for 30 minutes in an air-conditioned room with a room temperature of 20 to 25 and a humidity of 40 to 60% to adjust the skin surface temperature and humidity to the environment of the measurement space. During rest, water intake was limited. One investigator was measured for objective measurement, and the same area was measured at each measurement.
피부 리프팅 측정: 피부 리프팅 측정은 피부의 모습을 등고선으로 표현해 주는 기기인 F-ray를 사용하여 촬영한 이미지를 Image-pro plus로 눈꼬리, 볼, 입가 부위를 분석하여 실시하였다. Skin Lifting Measurement: Skin lifting measurement was performed by analyzing the image of the eyes, cheeks and mouth area using Image-pro plus for images taken using F-ray, a device that expresses the appearance of the skin in contours.
눈꼬리 리프팅은 눈꼬리 끝을 기준으로 직선을 그어 눈꼬리 끝 점에 걸치는 선과의 각도를 재어 평가하였다. 두 직선간의 각도가 커질수록 눈꼬리 리프팅 효과가 있음을 알 수 있다. The tail lifting was evaluated by drawing a straight line based on the tip of the tail and measuring the angle with the line across the tip of the tail. As the angle between the two straight lines increases, it can be seen that there is an eye tail lifting effect.
안면(볼) 리프팅은 광대뼈 근처에 형성된 원을 기준으로 원 가운데서 직선을 그어 입가에 걸치는 직선과의 각도를 재어 평가하였다. 두 직선간의 각도가 작아질수록 볼 리프팅 효과가 있음을 알 수 있다.Facial lifting was evaluated by drawing a straight line in the center of the circle based on the circle formed near the cheekbone and measuring the angle with the straight line across the mouth. It can be seen that the smaller the angle between the two straight lines has the ball lifting effect.
입가 리프팅은 입꼬리 끝을 기준으로 직선을 그어 입꼬리 끝 점과 광대뼈 근처에 형성된 원을 기준으로 원 가운데서 직선을 그어 내린 선과의 각도를 재어 평가하였다. 두 직선간의 각도가 커질수록 입가 리프팅 효과가 있음을 알 수 있다.Mouth lifting was evaluated by drawing a straight line based on the tip of the mouth and measuring the angle with the line drawn from the center of the circle based on the circle formed near the tip of the mouth and the cheekbones. As the angle between the two straight lines increases, it can be seen that there is a particle lifting effect.
피부 팔자 주름 측정: 피부 팔자 주름 측정은 3D 피부 촬영 장치 (Primos Pico)를 이용하여 시험 제품 사용 전과 사용 직후, 2주 후에 팔자 부분에 동일한 부위 촬영하였고, 저장된 이미지의 피부 주름 파라미터인 Ra(평균 거칠기: average roughness)값을 분석하였다.Skin-palm wrinkle measurement: The skin-palm wrinkle measurement was taken on the same area in the palm area before and immediately after using the test product using the 3D skin imaging device (Primos Pico), and after 2 weeks, Ra (mean roughness parameter) of the skin wrinkle parameter of the stored image. : average roughness) value was analyzed.
피부 목 주름 측정: 피부 목 주름 측정은 3D 피부 촬영 장치 (Primos Pico)를 이용하여 시험 제품 사용 전과 사용 직후, 2주 후에 목 부분에 동일한 부위 촬영하였고, 저장된 이미지의 피부 주름 파라미터인 Ra(평균 거칠기: average roughness)값을 분석하였다.Skin Neck Wrinkle Measurement: Skin neck wrinkle measurement was performed using 3D skin imaging device (Primos Pico) before and immediately after use of the test product, two weeks after the same part of the neck was taken, and the skin wrinkle parameter Ra (average roughness) of the stored image. : average roughness) value was analyzed.
피부 수분함유량 측정: 피부 수분함유량 측정은 Corneometer CM825(Courage-Khazaka electronic GmbH, Germany)를 사용하여 시험 제품 사용 전과 사용 직후, 2주 후에 측정하였다. 측정은 Corneometer probe를 피부에 접촉시켜 Sensor를 통해 3회 실시하여 그 평균값을 피부 수분함유량 평가 자료로 사용하였다. Corneometer 는 탐침이 접촉하는 곳의 정전용량(capacitance)을 측정하여 수분함량을 측정 할 수 있고, 단위는 단위상수인 A.U이며, 피부 보습량과 측정값은 비례한다.Skin moisture content measurement: Skin moisture content measurement was measured using Corneometer CM825 (Courage-Khazaka electronic GmbH, Germany) before and immediately after use of the test product and two weeks after use. The measurement was performed three times through the sensor by contacting the corneometer probe with the skin, and the average value was used as an evaluation data for skin moisture content. The corneometer can measure the moisture content by measuring the capacitance at the point of contact of the probe. The unit is A.U, which is a unit constant, and the skin moisturization and the measured value are proportional.
피부 각질 측정: 피부 각질 측정은 Visioscan VC98(Courage-Khazaka eletronic GmbH, Germany)을 사용하여 시험제품 사용 전과 직후, 2주 후에 측정하였다. 측정은 특수 필름(Corneofix)을 이용하여 볼 부위의 각질을 채취한 후, Visioscan VC98으로 영상을 촬영하고 분석하여 측정값 D.I(Desquamation Index: 표피탈락지수)를 피부 각질 평가 자료로 사용하였으며, 하기 식을 사용하여 산출하였다.Skin keratin measurement: The skin keratin measurement was measured before and immediately after using the test product and two weeks after using Visioscan VC98 (Courage-Khazaka eletronic GmbH, Germany). The measurement was performed by using a special film (Corneofix), and after taking the keratin of the cheek area, images were taken and analyzed by Visioscan VC98, and the measured value DI (Desquamation Index) was used as the evaluation data of the skin keratin. Calculated using.
Figure PCTKR2015004872-appb-I000008
Figure PCTKR2015004872-appb-I000008
상기 식에서, Where
D.I는 표피탈락지수(%)이고, A는 각질세포로 덮힌 면적의 백분율이고, Tn은 두께와 연관된 각질세포의 백분율이고, 그리고 n은 두께의 수준(1 내지 5)이다.D.I is the epidermal loss index (%), A is the percentage of area covered with keratinocytes, Tn is the percentage of keratinocytes associated with thickness, and n is the level of thickness (1-5).
유효성 설문조사(Global Assessment of Efficacy): 시험제품 사용 후 눈꼬리 리프팅, 입가 리프팅, 안면 처짐(볼 리프팅), 팔자주름, 목주름, 수분량, 각질 개선 효과 정도에 대하여 아주좋음(4), 좋음(3), 보통(2), 나쁨(1), 아주나쁨(0)의 5단계로 직접 설문자료에 답하도록 하였다. 연구자는 각 답변에 대한 시험대상자 수의 백분율을 구하여 시험제품의 효능 여부를 판단하였다.Global Assessment of Efficacy: Very good (4), good (3) for the degree of eyelid lifting, mouth lifting, facial sag (ball lifting), nasolabial folds, neck wrinkles, moisture content, and keratin improvement after using the test product ), Moderate (2), bad (1), very bad (0) in five steps to answer the questionnaire directly. The investigator determined the efficacy of the test product by obtaining the percentage of the subjects for each answer.
안전성 평가: 시험제품의 안전성은 시험제품을 사용한 모든 시험대상자를 대상으로 확인된 이상반응과 시험기간 동안 보고된 모든 이상반응을 종합하여 이상반응 발생률을 구하고 제품의 안전성 평가 자료로 사용하였다.Safety evaluation: The safety of the test product was calculated by integrating the identified adverse reactions among all subjects using the test product and all reported adverse reactions during the test period, and used as the safety evaluation data of the product.
제품 기호도 설문 조사평가: 시험제품 사용 후 제품 사용감에 대하여 시험대상자가 직접 설문자료에 답하도록 하였다. 평가항목은 피부 촉촉함, 매끄러움, 부드러움, 발림성, 향의 정도, 전반적 사용감에 대하여 조사하였으며, 아주 좋음(4), 좋음(3), 보통(2), 나쁨(1), 아주 나쁨(0)의 5단계로 평가하도록 하였다.Product preference survey evaluation: The test subjects were asked to answer the questionnaire directly about the product feeling after using the test product. The evaluation items were examined on skin moistness, smoothness, softness, spreadability, scent, and overall feeling of use, and were evaluated as good (4), good (3), moderate (2), bad (1), and bad (0). It was evaluated in five stages.
이상반응 평가: 시험제품 사용 중에 발생한 이상 피부증상에 대해서는 시험기간 동안 설문조사를 통하여 발생여부 및 증상정도를 확인하였다. 시험대상자가 이상증상을 느끼는 경우 시험담당자에게 즉시 보고하도록 지도하였다. 시험담당자는 이상반응이 보고되는 경우 책임연구자에게 이를 알리고, 책임연구자는 증상의 정도, 시험제품과의 연관 여부를 판단하고 증상에 대한 적절한 조치 및 시험참여 여부를 결정하였다.Adverse reaction evaluation: Abnormal skin symptoms occurred during the use of the test product were examined during the test period to determine the occurrence and symptoms. If the subject felt abnormal, he / she was instructed to report it immediately. The investigator informed the responsible investigator when an adverse reaction was reported, and the lead investigator judged the extent of the symptom, the association with the test product, and determined the appropriate measures for the symptom and participation in the test.
평가기준:Evaluation standard:
1차 유효성 평가 변수: 시험제품의 1차 유효성 평가 변수는 시험제품 사용 전과 후에 피부 수분함유량, 주름(이마, 눈가, 팔자), 모공, 기미 밝기, 리프팅, 속탄력, 복원력, 갈색 스팟 측정값을 근거로 평가하였다.Primary efficacy parameters: The primary efficacy parameters of the test product are measured before and after use of the test product, including skin moisture content, wrinkles (forehead, eyes, and limbs), pores, blemishes, lifting, fastness, resilience, and brown spot measurements. It evaluated on the basis.
2차 유효성 평가 변수: 시험제품의 2차 유효성 평가 변수는 시험제품 사용 후에 피부 개선 효과에 대한 유효성 평가 설문조사 결과를 근거로 평가하였다.Secondary efficacy evaluation variables: Secondary efficacy evaluation variables of the test product were evaluated based on the results of the efficacy survey for skin improvement effects after using the test product.
통계적 분석: 시험제품 사용 전 대비 측정값의 유의성 여부를 알아보기 위하여 통계분석 프로그램인 SPSS 19.0을 사용하였다. 95% 신뢰구간에서 유의확률 p<0.05 일 때 유의성을 확인하였으며, 유의확률은 소수 셋째자리까지 반올림하여 나타내었다. 연속형 변수는 평균과 표준편차로, 범주형 변수는 빈도와 백분율로 요약하였다. 3회 이상 반복측정 자료는 정규성 검정 모수적 방법으로 반복 측정 아노바(repeated measures ANOVA)를 사용하고, 본페로니(Bonferroni) 방법으로 사후검정 하였다. 비모수적 방법은 프리드만 검정(Friedman test)을, 윌콕슨 검정(Wilcoxon signed rank test)으로 짝 비교한 후 본페로니 방법으로 유의수준을 보정하여 사후검정하였다.Statistical analysis: We used SPSS 19.0, a statistical analysis program, to determine the significance of the measured values before using the test product. In the 95% confidence interval, the significance was confirmed when the significance probability was p <0.05, and the significance probability was expressed by rounding to the third decimal place. Continuous variables are summarized as mean and standard deviation, and categorical variables as frequency and percentage. Repeated measurements were repeated three times or more using the repeated measures ANOVA as the normality test parametric method and post-tested by the Bonferroni method. Nonparametric methods were compared by the Friedman test, Wilcoxon signed rank test, and then post-tested by correcting the significance level with the Bonferroni method.
실험결과들을 도 10(눈꼬리 리프팅), 도 11(입가 리프팅), 도 12(볼 리프팅), 도 13(팔자주름 개선), 도 14(목주름 개선), 도 15(피부 수분 함유량) 및 도 16(피부 각질 개선)에 나타내었다.Experimental results are shown in Fig. 10 (lifting the tail), Fig. 11 (lifting the mouth), Fig. 12 (ball lifting), Fig. 13 (improved nasolabial folds), Fig. 14 (improved neck wrinkles), Fig. 15 (skin moisture content) and Fig. 16 (Skin improvement).
도 10에 나타난 바와 같이, 시험제품 사용에 의한 눈꼬리 리프팅 수치의 변화를 확인하기 위하여 사용 전, 사용 2주 후의 눈꼬리 리프팅 각도를 측정하였다. 눈꼬리 리프팅 각도 측정값은 시험제품 사용 전 46.08±10.42, 사용 직후 46.78±10.56, 사용 2주 후 48.10±10.33로 나타났다. 피부 리프팅 각도 변화를 통계적 방법으로 유의성 여부를 검정하였다. 정규성 검정에 따라 모수적 방법인 반복 측정 아노바(post hoc Bonferroni correction)로 검정 한 결과, 눈꼬리 리프팅 각도가 사용 전에 비하여 사용 직후, 2주 후 모두 유의적으로 증가(p<0.05) 하였음을 확인할 수 있었다.As shown in Figure 10, in order to confirm the change of the tail lifting value by the use of the test product, the tail tail lifting angle before and after two weeks of use was measured. The tail lifting angle measurement was 46.08 ± 10.42 before use, 46.78 ± 10.56 immediately after use, and 48.10 ± 10.33 after 2 weeks of use. Changes in skin lifting angle were tested for statistical significance. As a result of the test by post hoc Bonferroni correction, which is a parametric method according to the normality test, it was confirmed that the tail lifting angle increased significantly (p <0.05) immediately after use and after 2 weeks compared to before use. there was.
도 11에 나타난 바와 같이, 시험제품 사용에 의한 입가 리프팅 수치의 변화를 확인하기 위하여 사용 전, 사용 2주 후의 입가 리프팅 각도를 측정하였다. 입가 리프팅 각도 측정값은 시험제품 사용 전 41.1±17.18, 사용 직후 41.70±7.07, 사용 2주 후 42.90±7.17로 나타났다. 피부 리프팅 각도 변화를 통계적 방법으로 유의성 여부를 검정하였다. 정규성 검정에 따라 모수적 방법인 repeated measures ANOVA (post hoc Bonferroni correction)로 검정 한 결과, 입가 리프팅 각도가 사용 전에 비하여 사용 직후, 2주 후 모두 유의적으로 증가(p<0.05) 하였음을 확인할 수 있었다.As shown in Figure 11, in order to confirm the change in the value of the lifting value by the use of the test product was measured before the use, 2 weeks after use. The value of the mouth lifting angle was 41.1 ± 17.18 before using the test product, 41.70 ± 7.07 immediately after use, and 42.90 ± 7.17 after 2 weeks of use. Changes in skin lifting angle were tested for statistical significance. According to the normalized test, repeated measures ANOVA (post hoc Bonferroni correction), which is a parametric method, showed that the mouth lifting angle increased significantly (p <0.05) immediately after and 2 weeks after use. .
도 12에 나타난 바와 같이, 시험제품 사용에 의한 볼 리프팅 수치의 변화를 확인하기 위하여 사용 전, 사용 2주 후의 볼 리프팅 각도를 측정하였다. 볼 리프팅 각도 측정값은 시험제품 사용 전 36.34±7.40, 사용 직후 35.74±7.33, 사용 2주 후 34.95±7.34로 나타났다. 피부 리프팅 각도 변화를 통계적 방법으로 유의성 여부를 검정하였다. 정규성 검정에 따라 모수적 방법인 repeated measures ANOVA (post hoc Bonferroni correction)로 검정 한 결과, 볼 리프팅 각도가 사용 전에 비하여 사용 직후, 2주 후 모두 유의적으로 감소(p<0.05) 하였음을 확인할 수 있었다.As shown in FIG. 12, the ball lifting angle was measured before use and 2 weeks after use in order to confirm the change of the ball lifting value by using the test product. The ball lifting angle measurement was 36.34 ± 7.40 before using the test product, 35.74 ± 7.33 immediately after using, and 34.95 ± 7.34 after 2 weeks of using. Changes in skin lifting angle were tested for statistical significance. According to the normalized test, the repeated measures ANOVA (post hoc Bonferroni correction), a parametric method, showed that the ball lifting angle was significantly decreased (p <0.05) immediately after and 2 weeks after use. .
도 13에 나타난 바와 같이, 시험제품 사용에 의한 팔자 주름 수치의 변화를 확인하기 위하여 사용 전, 사용 2주 후의 팔자 주름을 측정하였다. 팔자 주름 측정값은 시험제품 사용 전 19.87±2.96, 사용 직후 18.76±2.64, 사용 2주 후 18.32±2.86로 나타났다. 피부 팔자 주름 변화를 통계적 방법으로 유의성 여부를 검정하였다. 정규성 검정에 따라 비모수적 방법인 Friedman test(post hoc Wilcoxon signed rank test with Bonferroni correction)로 검정 한 결과, 팔자 주름이 사용 전에 비하여 사용 직후, 2주 후 모두 유의적으로 감소(p<0.025) 하였음을 확인할 수 있었다.As shown in FIG. 13, in order to confirm the change in the nasolabial folds caused by the use of the test product, the nasolabial folds were measured before use and two weeks after use. The nasolabial fold measurements were 19.87 ± 2.96 before using the test product, 18.76 ± 2.64 immediately after using the test product, and 18.32 ± 2.86 after 2 weeks of using the test product. The change of skin palsy was statistically tested for statistical significance. According to the normality test, the non-parametric Friedman test (post hoc Wilcoxon signed rank test with Bonferroni correction) showed that the nasolabial folds were significantly reduced (p <0.025) immediately after and 2 weeks after use. I could confirm it.
도 14에 나타난 바와 같이, 시험제품 사용에 의한 목주름 수치의 변화를 확인하기 위하여 사용 전, 사용 2주 후의 목주름을 측정하였다. 목주름 측정값은 시험제품 사용 전 23.88±2.75, 사용 직후 22.44±3.19, 사용 2주 후 21.79±2.88로 나타났다. 피부 목주름 변화를 통계적 방법으로 유의성 여부를 검정하였다. 정규성 검정에 따라 모수적 방법인 repeated measures ANOVA (post hoc Bonferroni correction)로 검정 한 결과, 목주름 각도가 사용 전에 비하여 사용 직후, 2주 후 모두 유의적으로 감소(p<0.05) 하였음을 확인할 수 있었다.As shown in FIG. 14, the neck wrinkles were measured before use and two weeks after use in order to confirm the change of the neck wrinkles caused by the use of the test product. The measured neck wrinkles were 23.88 ± 2.75 before use, 22.44 ± 3.19 immediately after use, and 21.79 ± 2.88 after 2 weeks of use. The change in skin wrinkles was tested by statistical method. According to the normalized test, repeated measures ANOVA (post hoc Bonferroni correction), a parametric method, showed that the neck angle decreased significantly (p <0.05) immediately after and 2 weeks after use. .
도 15에 나타난 바와 같이, 시험제품 사용에 의한 수분함유량 수치의 변화를 확인하기 위하여 사용 전, 사용 2주 후의 피부 수분함유량을 측정하였다. 피부 수분함유량 측정값은 시험제품 사용 전 61.48±9.33, 사용 직후 82.79±8.48, 사용 2주 후 71.96±7.56로 나타났다. 피부 수분함유량 변화를 통계적 방법으로 유의성 여부를 검정하였다. 정규성 검정에 따라 모수적 방법인 repeated measures ANOVA (post hoc Bonferroni correction)로 검정 한 결과, 수분함유량이 사용 전에 비하여 사용 직후, 2주 후 모두 유의적으로 증가(p<0.05) 하였음을 확인할 수 있었다.As shown in Figure 15, in order to confirm the change in the water content value by the use of the test product, the skin water content before and after two weeks of use was measured. Skin moisture content was 61.48 ± 9.33 before using test product, 82.79 ± 8.48 immediately after using, and 71.96 ± 7.56 after 2 weeks of using. Changes in skin moisture content were tested for statistical significance. According to the normalized test, repeated measures ANOVA (post hoc Bonferroni correction), which is a parametric method, showed that the water content increased significantly (p <0.05) immediately after and 2 weeks after use.
또한, 도 16에 나타난 바와 같이, 시험제품 사용에 의한 각질 수치의 변화를 확인하기 위하여 사용 전, 사용 2주 후의 피부 각질량을 측정하였다. 피부 각질 측정값은 시험제품 사용 전 19.59±2.59, 사용 직후 13.60±2.82, 사용 2주 후 15.48±2.61로 나타났다. 피부 각질 각도 변화를 통계적 방법으로 유의성 여부를 검정하였다. 정규성 검정에 따라 비모수적 방법인 Friedman test(post hoc Wilcoxon signed rank test with Bonferroni correction)로 검정 한 결과, 피부 각질이 사용 전에 비하여 사용 직후, 2주 후 모두 유의적으로 감소(p<0.025) 하였음을 확인할 수 있었다.In addition, as shown in Fig. 16, in order to confirm the change of the keratin level by the use of the test product, the skin angular mass after use and two weeks after the use was measured. Skin keratin measurements were 19.59 ± 2.59 before test product use, 13.60 ± 2.82 immediately after use, and 15.48 ± 2.61 after 2 weeks of use. The change in keratin angle of skin was statistically tested for significance. According to the normality test, the non-parametric method, Friedman test (post hoc Wilcoxon signed rank test with Bonferroni correction), showed that the skin keratin significantly decreased (p <0.025) immediately after and 2 weeks after use. I could confirm it.
유효성 평가 설문 조사결과: 시험제품 사용 후의 눈꼬리 리프팅, 입가 리프팅, 안면처짐(볼 리프팅), 팔자주름, 목주름, 수분량, 각질 개선 효과 정도에 대하여 실시한 설문조사에서 설문 값과 표준편차 및 답변에 대한 시험대상자 수의 백분율을 구하였으며, 그 결과를 하기 표 3에 나타내었다.Efficacy Assessment Survey Results: A survey on the questionnaire values, standard deviations, and answers in the survey conducted on the degree of effect of eye tail lifting, mouth lifting, facial sagging (ball lifting), nasolabial folds, neck wrinkles, moisture, and keratin improvement after using the test product. The percentage of the subjects was obtained and the results are shown in Table 3 below.
[표 3]TABLE 3
Figure PCTKR2015004872-appb-I000009
Figure PCTKR2015004872-appb-I000009
설문평가 결과, 눈꼬리 리프팅, 입가 리프팅, 안면처짐(볼 리프팅), 팔자 주름, 목주름, 수분량, 각질 개선 효과 정도에 대하여 시험대상자의 90% 이상이 보통 이상으로 평가하였다.As a result of the questionnaire evaluation, more than 90% of the subjects evaluated the degree of improvement of eye tail lifting, mouth lifting, facial sagging (ball lifting), nasolabial folds, neck wrinkles, moisture content, and keratin improvement.
제품 기호도 설문 조사결과: 제품 사용 후 설문조사로 시험제품의 피부 촉촉함, 매끄러움, 부드러움, 발림성, 향의 정도, 전반적 사용감 정도에 대하여 시험대상자가 느끼는 기호도를 조사하였다. 조사결과는 각 항목별 답변의 평균표준편차로 표시하였으며, 그 결과를 하기 표 4에 나타내었다.Results of Survey on Product Acceptance Survey: A survey was conducted after the use of the product to examine the degree of acceptance of the test subjects regarding the skin's moisture, smoothness, softness, spreadability, aroma, and overall feeling of use. The survey results were expressed as the average standard deviation of the answers for each item, the results are shown in Table 4 below.
[표 4]TABLE 4
Figure PCTKR2015004872-appb-I000010
Figure PCTKR2015004872-appb-I000010
조사 결과, 시험제품 기호도의 피부 촉촉함, 매끄러움, 부드러움, 발림성, 향의 정도, 전반적 사용감 정도에 대하여 시험대상자의 85% 이상이 보통 이상으로 평가하였다.As a result, more than 85% of the test subjects evaluated the skin moisture, smoothness, softness, spreadability, fragrance, and overall feeling of use of the test product as above average.
시험결과: 본 시험에서는 20 내지 55세의 여성을 대상으로 시험제품을 정해진 시험부위에 1회 및 2주간 사용하게 한 후 제품 사용 전과 직후, 2주 후에 피부 눈꼬리 리프팅, 입가 리프팅, 안면(볼) 리프팅, 팔자 주름, 목주름, 수분함유량, 각질을 측정하였다. 시험 종료 후 시험대상자 설문평가를 완료하여 다음과 같은 결론을 얻었다.Test Results: In this study, the test product was used for women aged 20 to 55 years once and for 2 weeks before and immediately after using the product, and after 2 weeks. Lifting, nasolabial folds, neck wrinkles, moisture content, and keratin were measured. After the completion of the test, the subjects' survey was completed, and the following conclusions were obtained.
1) 본 시험에 참여한 시험대상자 21명은 모두 여성으로 평균연령은 만 40.05세였고, 총 21명 모두 시험을 종료하였다. 선정된 시험대상자들은 특별한 피부 증상은 없었으며 시험에 영향을 미칠 수 있는 질환 및 약물 복용력은 없었다.1) The 21 subjects who participated in this study were all women, and the average age was 40.05 years. The selected subjects had no specific skin symptoms and no history of disease or medication that could affect the study.
2) 시험제품 사용 후 눈꼬리 리프팅을 측정한 결과, 각도 측정값이 사용 직후, 2주 후 모두 유의적으로 증가(p<0.05)하였다.2) As a result of measuring the tail of the eye after using the test product, the angle measurement value increased significantly (p <0.05) immediately after the use and after 2 weeks.
3) 시험제품 사용 후 입가 리프팅을 측정한 결과, 각도 측정값이 사용 직후, 2주 후 모두 유의적으로 증가(p<0.05)하였다.3) After the use of the test product, the value of the grain size lifting was measured. As a result, the angle measurement value increased significantly (p <0.05) immediately after use and 2 weeks later.
4) 시험제품 사용 후 안면(볼) 리프팅을 측정한 결과, 각도 측정값이 사용 직후, 2주 후 모두 유의적으로 감소(p<0.05)하였다.4) As a result of measuring facial lifting after using the test product, the angle measurement value was significantly decreased (p <0.05) immediately after use and after 2 weeks.
5) 시험제품 사용 후 팔자주름을 측정한 결과, 팔자주름 측정값이 사용 직후, 2주 후 모두 유의적으로 감소(p<0.025)하였다.5) As a result of measuring the size of the nasolabial fold after using the test product, the measured value of the nasolabial fold decreased immediately after use and 2 weeks after the use (p <0.025).
6) 시험제품 사용 후 목주름을 측정한 결과, 목주름 측정값이 사용 직후, 2주 후 모두 유의적으로 감소(p<0.05)하였다.6) As a result of measuring neck wrinkles after using test product, neck wrinkles measured value decreased significantly (p <0.05) immediately after use and after 2 weeks.
7) 시험제품 사용 후 수분함유량을 측정한 결과, 수분함유량 측정값이 사용 직후, 2주 후 모두 유의적으로 증가(p<0.05)하였다.7) As a result of measuring the water content after using the test product, the measured water content increased significantly (p <0.05) both immediately after use and after 2 weeks.
8) 시험제품 사용 후 각질을 측정한 결과, 각질량 측정값이 사용 직후, 2주 후 모두 유의적으로 감소(p<0.025)하였다.8) As a result of measuring keratin after using the test product, the measured angular mass was significantly decreased (p <0.025) immediately after use and 2 weeks later.
9) 시험제품에 대한 유효성 평가 설문조사 결과, 눈꼬리 리프팅, 입가 리프팅, 안면(볼) 리프팅, 팔자 주름, 목주름, 수분함유량, 각질 개선 효과에 대하여 시험대상자의 90% 이상이 보통 이상으로 평가하였다.9) The results of the survey on the effectiveness of the test product showed that more than 90% of the test subjects rated the eye tail lifting, the mouth lifting, the face (ball) lifting, the nasolabial folds, the neck wrinkles, the moisture content, and the keratin improvement effect. .
10) 본 시험제품을 21명의 시험대상자가 사용하는 동안 이상반응에 대한 보고는 전혀 없었으며, 피부과 전문의에 의한 이학적 검사 상으로도 홍반, 발진 및 소양감 등 피부 이상소견은 관찰되지 않았다.10) There were no reports of adverse reactions during the use of this test product by 21 subjects, and no skin abnormalities such as erythema, rash and pruritus were observed by the dermatologist.
따라서 본 발명에 따른 화장조성물은 1회 사용으로 즉각적 눈꼬리 리프팅 개선, 입가 리프팅 개선, 안면 처짐(볼 리프팅) 개선, 팔자 주름 개선, 목주름 개선, 수분량 개선, 각질 개선에 도움을 주며, 2주 사용으로 눈꼬리 리프팅 개선, 입가 리프팅 개선, 안면 처짐(볼 리프팅) 개선, 팔자 주름 개선, 목주름 개선, 수분량 개선, 각질 개선에 도움을 주는 제품으로 판단된다.Therefore, the cosmetic composition according to the present invention provides immediate eye tail lifting improvement, mouth lifting improvement, facial sag (ball lifting) improvement, nasolabial fold improvement, neck wrinkle improvement, moisture content improvement, keratin improvement by two-time use, and use for two weeks. It is believed to be a product that helps to improve eye tail lifting, mouth lifting, facial sagging (ball lifting), nasolabial folds, neck wrinkles, moisture, and keratin.
본 발명은 장업 분야에서 이용될 수 있다.The present invention can be used in the field of industry.

Claims (5)

  1. 80 내지 100%의 범위 이내의 탈아세틸화도(DA: Degree of Deacetylation) 및 3.5 내지 7.5의 범위 이내의 pH를 갖는 용매에서 1 내지 15분의 범위 이내의 용해속도로 용해되는 속용성을 갖는 키토산 0.5 내지 6.0중량%; 및 잔량으로서 3.5 내지 7.5의 범위 이내의 pH를 갖는 용매;를 포함하되, 상기 키토산이 상기 용매로부터 물리적으로 분리되어 용해되어 있지 않은 상태로 포함됨을 특징으로 하는 속용성을 갖는 키토산을 포함하는 피부 리프팅용 화장조성물.Chitosan 0.5 having rapid solubility that dissolves in a solvent having a degree of deacetylation (DA) within the range of 80 to 100% and a pH within the range of 3.5 to 7.5 at a dissolution rate within the range of 1 to 15 minutes. To 6.0 weight percent; And a solvent having a pH within a range of 3.5 to 7.5 as a residual amount, wherein the chitosan is physically separated from the solvent and is not dissolved. Cosmetic makeup composition.
  2. 제 1 항에 있어서,The method of claim 1,
    상기 키토산이 90 내지 100%의 범위 이내의 탈아세틸화도를 갖는 것임을 특징으로 하는 속용성을 갖는 키토산을 포함하는 피부 리프팅용 화장조성물.The cosmetic composition for skin lifting comprising chitosan, characterized in that the chitosan has a degree of deacetylation within the range of 90 to 100%.
  3. 제 1 항 또는 제 2 항에 있어서, The method according to claim 1 or 2,
    상기 키토산이 0.010 내지 0.050㎜의 범위 이내의 굵기를 갖는 섬유상 키토산일 수 있으며, 섬유상 키토산은 1.7 내지 4.0중량%의 범위 이내의 양으로 포함됨을 특징으로 하는 속용성을 갖는 키토산을 포함하는 피부 리프팅용 화장조성물.The chitosan may be fibrous chitosan having a thickness within the range of 0.010 to 0.050 mm, and the fibrous chitosan is included in an amount within the range of 1.7 to 4.0% by weight for skin lifting, including chitosan having rapid solubility. Cosmetic composition.
  4. 제 1 항 또는 제 2 항에 있어서, The method according to claim 1 or 2,
    상기 키토산이 0.150 내지 0.450㎜의 범위 이내의 평균굵기를 갖는 분말상 키토산일 수 있으며, 분말상 키토산은 2.6 내지 6.0중량%의 범위 이내의 양으로 포함됨을 특징으로 하는 속용성을 갖는 키토산을 포함하는 피부 리프팅용 화장조성물.The chitosan may be a powdered chitosan having an average thickness within the range of 0.150 to 0.450mm, the powdered chitosan is contained in an amount within the range of 2.6 to 6.0% by weight skin lifting comprising chitosan having a quick solubility Cosmetic makeup composition.
  5. 제 1 항에 있어서,The method of claim 1,
    상기 용매가 물; 또는 글리콜릭산, 젖산, 락틱산, 시트릭산, 사과산, 주석산, 구연산, 아스코르빅산(비타민 C), 아스코르빌포스페이트, 아스코르빌글루코사이드, 마그네슘아스코르빌포스페이트, 소디움아스코르빌포스페이트, 아스코르빌팔미테이트 및 이들 중 2이상의 혼합물로 이루어지는 군으로부터 선택되는 pH조절제가 용해된 산성수;임을 특징으로 하는 속용성을 갖는 키토산을 포함하는 피부 리프팅용 화장조성물.The solvent is water; Or glycolic acid, lactic acid, lactic acid, citric acid, malic acid, tartaric acid, citric acid, ascorbic acid (vitamin C), ascorbyl phosphate, ascorbyl glucoside, magnesium ascorbyl phosphate, sodium ascorbyl phosphate, ascorbic A cosmetic composition for skin lifting comprising chitosan having a rapid solubility, wherein the pH adjuster selected from the group consisting of bilpalmitate and a mixture of two or more thereof is dissolved.
PCT/KR2015/004872 2014-05-14 2015-05-14 Skin lifting cosmetic composition containing chitosan having fast dissolving property WO2015174772A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140057996A KR20140113614A (en) 2014-05-14 2014-05-14 DIY Natural Cosmetics using Chitosan and the preparation method thereof
KR10-2014-0057996 2014-05-14

Publications (2)

Publication Number Publication Date
WO2015174772A1 WO2015174772A1 (en) 2015-11-19
WO2015174772A9 true WO2015174772A9 (en) 2016-06-09

Family

ID=51757853

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/004872 WO2015174772A1 (en) 2014-05-14 2015-05-14 Skin lifting cosmetic composition containing chitosan having fast dissolving property

Country Status (2)

Country Link
KR (3) KR20140113614A (en)
WO (1) WO2015174772A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
US11110049B2 (en) 2017-06-23 2021-09-07 The Procter & Gamble Company Composition and method for improving the appearance of skin
US11583488B2 (en) 2020-06-01 2023-02-21 The Procter & Gamble Company Method of improving penetration of a vitamin B3 compound into skin
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210012144A (en) 2019-07-24 2021-02-03 민현경 Diy kit for manufacturing natural cosmetic
KR102099269B1 (en) 2020-01-22 2020-04-10 신승연 Two-part skin care formulations
KR20210148784A (en) 2020-06-01 2021-12-08 농업회사법인유한회사 성우 Cosmetic preparation using cynanchum wilfordii Hemsley
KR20220099669A (en) 2021-01-07 2022-07-14 (주)심플스틱 Cosmetic composition used for skin lifting for anti-aging and method of thermal skin care using the same
FR3131840A1 (en) * 2022-01-19 2023-07-21 L'oreal COMPOSITION COMPRISING A SOLUBILIZED POLYPHENOL
WO2023120260A1 (en) * 2021-12-20 2023-06-29 L'oreal Composition comprising solubilized polyphenol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675535A5 (en) * 1988-11-28 1990-10-15 Nestle Sa
JPH05294822A (en) * 1992-04-15 1993-11-09 Nichigou Film Kk Article for improving environment to be added to water for used
JP2003524635A (en) * 1999-12-23 2003-08-19 アイヴリア インコーポレイテッド Chitosan biopolymer for topical delivery of active agents
JP5116129B2 (en) * 2000-09-01 2013-01-09 日本水産株式会社 Manufacturing method of neutral chitosan aqueous solution
KR20120029598A (en) * 2010-09-17 2012-03-27 (주)크론바이오 Pack using chitosan and method of preparing the same

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11110049B2 (en) 2017-06-23 2021-09-07 The Procter & Gamble Company Composition and method for improving the appearance of skin
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
US11583488B2 (en) 2020-06-01 2023-02-21 The Procter & Gamble Company Method of improving penetration of a vitamin B3 compound into skin
US11911498B2 (en) 2020-06-01 2024-02-27 The Procter & Gamble Company Low pH skin care composition and methods of using the same

Also Published As

Publication number Publication date
KR101850053B1 (en) 2018-04-24
KR20140113614A (en) 2014-09-24
KR20150132011A (en) 2015-11-25
KR101596634B1 (en) 2016-02-25
KR20150132039A (en) 2015-11-25
WO2015174772A1 (en) 2015-11-19

Similar Documents

Publication Publication Date Title
WO2015174772A9 (en) Skin lifting cosmetic composition containing chitosan having fast dissolving property
CN107007492A (en) A kind of makeup remover and preparation method thereof
CN102935055B (en) Hydrolat moisturizing facial mask
EP0149872B1 (en) Cosmetic composition containing glycoproteins for the skin care
EP2404642A2 (en) Process for preparing a cosmetic composition having an immediate lifting effect
US20230099298A1 (en) Cosmetic mask for application to the skin, and method for applying same
CN104771335B (en) Anti-dandruff nourishing essence dew of plant and preparation method thereof
JP4906509B2 (en) Modified silk and its aqueous extract
CN105997625B (en) A kind of moist newborn and its application for child skin mucous membrane operational maintenance
US20180303969A1 (en) Composition and method for treating wounds and inflammatory conditions
CN112587436A (en) Medical dressing containing recombinant collagen and preparation method thereof
KR102496383B1 (en) Composition for Improving Symptom of Atopic Skin Containing Poly-Gamma-glutamic Acid
CN108576812A (en) Composition with fat melting refreshing effect and its processing method
CN110974716B (en) Composition for preventing and treating striae gravidarum
WO2017142158A1 (en) Composition for skin anti-aging and wrinkle reduction, containing medicinal herb mixture extract as active ingredient
Davies et al. Comparative efficacy of shampoos containing coal tar (4.0% w/w; Tarmed™), coal tar (4.0% w/w) plus ciclopirox olamine (1.0% w/w; Tarmed™ AF) and ketoconazole (2.0% w/w; Nizoral™) for the treatment of dandruff/seborrhoeic dermatitis
WO2016204320A1 (en) Massage device
CN110075033A (en) A kind of edelweiss skin care moisturizing aerosol and preparation method thereof
CN116687778B (en) Mild, tear-free and eye-penetrating and non-irritating amino acid facial cleansing foam for children and preparation method thereof
WO2017094958A1 (en) Composition for improving skin aging and wrinkles, containing coptis teeta wall. and trichosanthes kirilowii mixture extract as active ingredient
JP2000169327A (en) Low irritant preparation for external use for skin and bathing agent
US20050036972A1 (en) System for managing pathogens and irritants and monitoring usage of anti-bacterial formulations
CN102283797B (en) Pouch-removing eye mask and preparation method thereof
KR101989784B1 (en) Discoloration evaluation model for cosmetics and method for measurement of discoloration of cosmetics using the same
Alkubaisi Does Personal Protective equipment Lead To Skin Damages

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15792737

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC

122 Ep: pct application non-entry in european phase

Ref document number: 15792737

Country of ref document: EP

Kind code of ref document: A1